≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Adrenocortical insufficiency

DOID EFO Endpoint Browser PheWeb

E4_ADDISON

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E27.1, E27.2, E27.3#, E27.4
  • Hospital discharge: ICD-9 — 2554
  • Hospital discharge: ICD-8 — 2551
  • Cause of death: ICD-10 — E27.1, E27.2, E27.3#, E27.4
  • Cause of death: ICD-9 — 2554
  • Cause of death: ICD-8 — 2551
  • KELA reimbursements: KELA codes — 105

3 out of 7 registries used, show all original rules.

1301

4. Check minimum number of events

None

1301

5. Include endpoints

None

1301

6. Filter based on genotype QC (FinnGen only)

1301

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7708 4664 2983
Only index persons 6408 3987 2421
Unadjusted period prevalence (%)
Whole population 0.11 0.13 0.08
Only index persons 0.13 0.15 0.09
Median age at first event (years)
Whole population 52.50 53.53 50.87
Only index persons 52.56 53.14 51.61

-FinnGen-

Key figures

All Female Male
Number of individuals 1301 857 444
Unadjusted period prevalence (%) 0.26 0.29 0.20
Median age at first event (years) 55.01 52.47 59.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1155
Matched controls
11548
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB09
ATC
hydrocortisone; systemic
944.0
323.0
946
55
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
323.0
370
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
323.0
338
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
9261.1
323.0
533
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
5087.5
323.0
368
*
H02AA02
ATC
fludrocortisone; oral
184.8
287.3
291
21
H02AB06
ATC
prednisolone; systemic
4.5
123.2
786
3716
J45.9
ICD-10 Finland
Asthma, unspecified
5.2
112.4
430
1188
E27.2
ICD-10 Finland
Addisonian crisis
+∞
112.3
106
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
106.7
597
2376
E23.03
ICD-10 Finland
Lack of ACTH
+∞
105.9
100
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
5.1
103.3
396
1079
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.6
100.3
219
275
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.3
90.5
424
1382
H03AA01
ATC
levothyroxine sodium; systemic
4.0
89.4
473
1715
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
12.9
88.0
162
144
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
84.4
80
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
83.2
673
3377
R03BB04
ATC
tiotropium bromide; inhalant
5.9
79.4
245
501
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
78.6
506
2106
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
9.8
77.2
164
192
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.7
75.8
243
518
R03DC03
ATC
montelukast; oral
4.1
74.0
340
1055
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
65.4
73.7
85
14
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.4
72.6
303
856
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
71.6
68
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.7
71.4
398
1451
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
70.1
239
544
R50.9
ICD-10 Finland
Fever, unspecified
4.2
66.7
295
872
C03CA01
ATC
furosemide; systemic
3.3
65.9
443
1845
R03AK08
ATC
formoterol and beclometasone; inhalant
9.5
65.0
140
166
J45.1
ICD-10 Finland
Nonallergic asthma
6.0
64.9
195
379
J46
ICD-10 Finland
Status asthmaticus
12.2
64.5
121
110
R53
ICD-10 Finland
Malaise and fatigue
3.4
64.4
386
1468
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
4.1
59.2
267
794
R11
ICD-10 Finland
Nausea and vomiting
5.2
59.0
201
451
M05BA04
ATC
alendronic acid; oral
5.2
57.9
195
431
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.2
57.2
244
687
N02AA05
ATC
oxycodone; systemic
4.0
57.2
266
811
R03AC12
ATC
salmeterol; inhalant
7.5
56.1
139
206
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
53.3
366
1501
J45.8
ICD-10 Finland
Mixed asthma
9.3
51.5
111
131
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
51.1
261
853
J01MA12
ATC
levofloxacin; systemic
3.3
50.8
310
1162
R06.0
ICD-10 Finland
Dyspnoea
2.9
50.5
395
1755
R03DA04
ATC
theophylline; systemic, rectal
6.6
50.2
137
232
UJF32
NOMESCO Finland
Coloscopy
2.8
49.0
399
1809
R03BA05
ATC
fluticasone; inhalant
3.1
48.4
328
1318
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
47.7
256
866
R96
ICPC
Asthma
4.4
47.6
189
491
25510
ICD-8 Finland
Diseases of adrenal glands, Adrenal cortical hypofunction
+∞
46.1
44
*
WZC30
NOMESCO Finland
Teaching
3.5
46.0
246
826
H02AB04
ATC
methylprednisolone; systemic
3.3
45.4
262
933
J01MA14
ATC
moxifloxacin; systemic
4.4
45.2
180
468
N03AX12
ATC
gabapentin; oral
3.2
44.9
272
1003
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
11.1
44.9
87
84
H02AB07
ATC
prednisone; oral
3.3
44.4
256
910
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
+∞
44.0
42
*
L04AX01
ATC
azathioprine; systemic
6.3
44.0
123
214
N03AX16
ATC
pregabalin; oral
2.8
43.8
367
1672
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
43.5
329
1407
R03AC02
ATC
salbutamol; inhalant
2.4
43.1
702
4556
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
42.8
248
881
J01MA02
ATC
ciprofloxacin; systemic
2.4
42.7
524
2945
XG474
NOMESCO Finland
Exhalation nntrogen oxide
8.0
42.1
99
134
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
42.1
500
2756
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.5
41.8
160
398
R03BA08
ATC
ciclesonide; inhalant
4.0
41.3
180
507
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.8
41.0
323
1407
AA1AD
NOMESCO Finland
CT of head and brain
2.7
40.4
340
1540
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.8
40.3
189
567
A02BC02
ATC
pantoprazole; systemic
2.4
40.2
810
5745
H05AA02
ATC
teriparatide; parenteral
+∞
39.8
38
*
318
Kela drug reimbursment
Teriparatide
400.5
39.3
39
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
7.4
39.1
96
139
S97
ICPC
Chronic ulcer skin
5.7
39.0
118
226
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
39.0
223
778
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
38.7
150
377
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
38.6
211
713
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
389.7
38.3
38
*
A02BC05
ATC
esomeprazole; systemic
2.3
37.8
550
3296
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
28.0
37.5
51
19
A41.9
ICD-10 Finland
Sepsis, unspecified
7.2
37.2
93
138
A07AA02
ATC
nystatin; oral
4.5
37.2
140
341
N06AX21
ATC
duloxetine; oral
3.4
37.2
202
677
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.7
36.6
132
308
R03BA01
ATC
beclometasone; inhalant
3.0
36.5
236
897
SPAT1254
SPAT
Administration of medicine
3.0
36.4
239
917
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
62.2
36.4
42
7
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
36.3
165
479
E27.0
ICD-10 Finland
Other adrenocortical overactivity
368.3
36.2
36
*
SPAT1263
SPAT
Sampling
2.2
35.9
559
3427
N02AX02
ATC
tramadol; systemic, rectal
2.2
35.9
551
3358
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.8
35.9
168
500
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.6
35.7
109
211
104
Kela drug reimbursment
Thyroid insufficiency
4.1
35.5
151
413
SPAT1262
SPAT
Handing over of treatment supplies
2.7
35.5
278
1194
R03AC13
ATC
formoterol; inhalant
4.9
35.3
121
267
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.1
35.1
147
396
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
35.1
273
1166
R03DC01
ATC
zafirlukast; oral
11.8
34.9
65
58
C07AB07
ATC
bisoprolol; oral
2.2
34.6
559
3465
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.8
34.4
75
90
N06AA09
ATC
amitriptyline; systemic
3.4
33.9
179
586
E0000UV
ATC
NA
2.2
33.7
525
3192
A02BC01
ATC
omeprazole; systemic
2.4
33.6
381
1993
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
+∞
33.5
32
*
J45
ICD-10 Finland
Asthma
3.3
33.4
185
628
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.9
33.2
114
252
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
33.0
256
1086
M05BX04
ATC
denosumab; parenteral
5.2
33.0
107
222
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
25.2
32.9
46
19
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
32.7
144
405
A02BA02
ATC
ranitidine; systemic
2.6
32.5
291
1340
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
32.0
188
665
J01FF01
ATC
clindamycin; systemic
2.3
31.9
372
1963
N05BA04
ATC
oxazepam; oral
2.4
31.8
348
1781
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
31.6
279
1273
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
31.6
145
423
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
31.4
30
*
2554A
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]
+∞
31.4
30
*
C03DA01
ATC
spironolactone; oral
3.4
31.3
168
555
G47.3
ICD-10 Finland
Sleep apnoea
2.5
31.3
286
1330
A01AB09
ATC
miconazole; local oral
3.5
31.1
161
517
R51.80
ICD-10 Finland
Headache
2.8
31.0
230
947
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.8
30.8
91
169
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.6
30.6
93
179
SPAT1153
SPAT
Removal of sutures
2.2
30.4
417
2362
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
30.3
29
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
30.0
309
1523
J02AC01
ATC
fluconazole; systemic
2.1
30.0
535
3390
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
29.5
149
469
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
+∞
29.3
28
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
29.2
326
1671
R06AE07
ATC
cetirizine; oral
2.0
28.8
553
3589
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.5
28.7
46
29
A02BC03
ATC
lansoprazole; oral
2.2
28.6
384
2142
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.3
28.5
112
283
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
27.8
366
2019
R01AD01
ATC
beclometasone; nasal
2.6
27.6
233
1027
N06AX16
ATC
venlafaxine; oral
2.6
27.1
217
928
S18
ICPC
Laceration/cut
2.0
27.1
515
3304
R03BA02
ATC
budesonide; inhalant
2.4
27.1
264
1259
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
26.9
178
678
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
26.8
521
3367
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.4
26.7
100
241
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
26.7
243
1116
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.3
26.6
142
466
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.9
26.5
176
671
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
26.5
433
2610
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
26.4
508
3264
A06AD11
ATC
lactulose; oral
2.7
26.2
204
858
A46
ICD-10 Finland
Erysipelas
2.7
26.1
194
793
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
25.9
136
440
R02
ICPC
Shortness of breath/dyspnoea
2.8
25.9
179
699
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
25.7
253
1209
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
45.4
25.6
31
7
R03BB01
ATC
ipratropium bromide; inhalant
5.1
25.6
83
172
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
25.6
303
1582
ZX120
NOMESCO Finland
Intravenous
3.1
25.5
157
566
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.6
25.3
122
369
N06AX11
ATC
mirtazapine; oral
2.0
25.2
406
2421
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
25.1
557
3753
N02BE01
ATC
paracetamol; systemic, rectal
2.3
25.1
996
8408
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
25.0
156
570
E87.6
ICD-10 Finland
Hypokalaemia
6.0
25.0
70
122
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.1
24.9
62
92
SPAT1301
SPAT
No procedures
2.0
24.2
402
2417
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.4
24.1
122
383
N05CF01
ATC
zopiclone; oral
2.0
24.0
405
2447
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
23.9
394
2358
J01FA06
ATC
roxithromycin; oral
1.9
23.8
498
3262
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.6
23.6
84
193
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
23.5
623
4436
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.3
23.3
73
146
R52.2
ICD-10 Finland
Other chronic pain
5.2
23.1
73
147
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
23.1
63
106
C01CA24
ATC
epinephrine; parenteral
3.6
23.1
109
324
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.7
23.0
80
179
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
22.9
333
1888
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.2
22.8
91
233
N05BA01
ATC
diazepam; systemic, rectal
2.5
22.8
200
893
SPAT1255
SPAT
Intravenous administration of medicine
3.6
22.8
109
327
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
22.7
150
565
N03AE01
ATC
clonazepam; systemic
3.6
22.7
109
328
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
22.7
171
702
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
22.3
503
3361
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
22.3
152
585
M81.4
ICD-10 Finland
Drug-induced osteoporosis
27.9
22.3
30
11
SPAT1260
SPAT
Consultation of another employee
2.3
22.2
250
1262
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
13.0
22.2
39
31
J01DB01
ATC
cefalexin; oral
2.1
22.1
945
7900
P01BA02
ATC
hydroxychloroquine; oral
3.0
22.1
134
478
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.3
22.0
116
376
R01AD08
ATC
fluticasone; nasal
2.0
21.9
369
2213
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
44.2
21.5
26
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
21.4
104
316
J47
ICD-10 Finland
Bronchiectasis
7.6
21.3
50
68
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.9
21.3
90
243
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
21.3
358
2139
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.3
21.3
81
199
R03AK11
ATC
formoterol and fluticasone; inhalant
5.9
21.2
60
106
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.2
21.2
116
386
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
21.0
174
752
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.9
20.9
59
104
N06AB04
ATC
citalopram; systemic
2.1
20.8
277
1503
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
11.9
20.8
38
33
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.8
20.8
145
567
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.0
20.6
85
225
A07EC01
ATC
sulfasalazine; oral, rectal
3.0
20.6
126
452
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
20.6
239
1220
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
20.5
189
864
R06AE09
ATC
levocetirizine; oral
2.3
20.5
203
962
N03AX09
ATC
lamotrigine; oral
3.9
20.5
88
241
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
20.5
158
655
SPAT1310
SPAT
Counselling related to known health issue
1.9
20.5
391
2444
R03AC03
ATC
terbutaline; inhalant
2.4
20.4
200
944
SPAT1325
SPAT
Vaccination
1.9
20.4
424
2728
WX892
NOMESCO Finland
Monitored bed care
3.1
20.4
117
403
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
20.3
125
450
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.9
20.3
68
147
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
20.2
524
3631
NF1AA
NOMESCO Finland
Hip X-ray examination
3.0
20.2
122
435
R06AX26
ATC
fexofenadine; oral
3.3
20.2
107
348
B01AB05
ATC
enoxaparin; parenteral
1.9
20.0
367
2256
L28
ICPC
Limited function/disability (L)
2.3
20.0
213
1046
XG410
NOMESCO Finland
Flow-volume spirometry
4.3
19.9
76
187
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
19.9
175
781
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
19.8
138
537
M54.5
ICD-10 Finland
Low back pain
1.9
19.8
402
2560
TAB00
NOMESCO Finland
Lumbar puncture
3.8
19.7
87
244
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
29.5
19.7
26
9
J01FA09
ATC
clarithromycin; systemic
1.9
19.6
392
2481
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.8
19.5
56
101
A28
ICPC
Limited function/disability NOS
2.4
19.5
182
835
E87.5
ICD-10 Finland
Hyperkalaemia
9.0
19.5
41
47
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
9.8
19.4
39
41
121
Kela drug reimbursment
Severe hypofunction of sexual glands
7.4
19.4
46
64
A07EA06
ATC
budesonide; oral, local oral
4.4
19.4
72
173
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
19.3
151
631
A07AA09
ATC
vancomycin; oral
8.8
19.3
41
48
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
19.2
125
468
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.3
19.2
59
116
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
19.0
211
1054
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.2
19.0
46
66
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.2
19.0
106
355
J01FA10
ATC
azithromycin; systemic
1.8
19.0
675
5128
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.2
19.0
74
186
ZXA10
NOMESCO Finland
Bilateral
2.1
18.9
240
1272
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.2
18.9
73
182
R01AD09
ATC
mometasone; nasal
1.8
18.9
531
3749
102
Kela drug reimbursment
Diabetes insipidus
+∞
18.8
18
*
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
+∞
18.8
18
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
28.3
18.8
25
9
D07AA02
ATC
hydrocortisone; topical
2.3
18.7
186
879
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
18.7
133
526
E000001
ATC
NA
2.1
18.7
260
1430
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
193.0
18.6
19
*
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.4
18.5
69
166
N05AH04
ATC
quetiapine; oral
2.2
18.5
213
1078
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
8.1
18.4
41
52
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.1
18.3
73
188
TGC00
NOMESCO Finland
Bronchial lavation
5.9
18.1
51
90
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
18.1
124
477
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
6.3
18.0
48
79
A12AA04
ATC
calcium carbonate; oral
10.9
18.0
34
32
R55
ICD-10 Finland
Syncope and collapse
2.6
17.9
141
590
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
17.9
109
390
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
17.9
146
624
A10AE05
ATC
insulin detemir; parenteral
3.4
17.8
89
277
TQW80
NOMESCO Finland
Local dermatologic skincare
5.0
17.8
58
122
BCA30
NOMESCO Finland
Unilateral adrenalectomy
67.7
17.8
20
*
M25.5
ICD-10 Finland
Pain in joint
1.9
17.8
339
2095
H01AC01
ATC
somatropin; parenteral
+∞
17.7
17
*
E25.00
ICD-10 Finland
Congenital salt-losing adrenal hyperplasia
+∞
17.7
17
*
SPAT1229
SPAT
Assessment of need for aid
2.9
17.7
115
428
N03AG01
ATC
valproic acid; systemic, rectal
3.2
17.7
97
323
M79.7
ICD-10 Finland
Fibromyalgia
4.2
17.7
68
169
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
17.7
352
2209
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
17.6
326
1995
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.1
17.5
48
82
M70.6
ICD-10 Finland
Trochanteric bursitis
2.4
17.5
160
725
JN4BD
NOMESCO Finland
Extensive body CT
2.5
17.5
149
650
J01AA02
ATC
doxycycline; systemic
1.8
17.4
877
7323
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
17.4
98
332
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
17.4
436
2947
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
17.3
90
289
A11CC03
ATC
alfacalcidol; systemic
7.1
17.3
42
61
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
17.3
347
2180
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.5
17.2
61
140
A10AE04
ATC
insulin glargine; parenteral
2.7
17.2
121
475
D07AC01
ATC
betamethasone; topical
1.8
17.1
398
2619
R60.0
ICD-10 Finland
Localized oedema
2.4
17.0
154
693
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
17.0
60
137
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.6
17.0
60
137
L04AA06
ATC
mycophenolic acid; systemic
6.7
17.0
43
66
Z01.9
ICD-10 Finland
Special examination, unspecified
3.4
17.0
86
270
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.8
16.9
48
86
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
16.9
464
3217
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
16.9
188
937
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
16.8
95
322
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.3
16.8
89
289
N05CD07
ATC
temazepam; oral
2.3
16.8
161
747
H04AA01
ATC
glucagon; nasal, parenteral
4.8
16.8
56
121
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
16.8
118
463
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.9
16.8
70
188
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.3
16.7
85
268
E31.00
ICD-10 Finland
APECED syndrome
+∞
16.7
16
*
106
Kela drug reimbursment
Hypoparathyroidism
+∞
16.7
16
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.8
16.6
56
122
SPAT1312
SPAT
General health counselling
1.8
16.6
395
2616
R5140
NOMESCO Finland
Monitoring the use of the aid
2.5
16.6
136
582
ZX114
NOMESCO Finland
Intramuscular
7.4
16.6
39
54
L04AA13
ATC
leflunomide; oral
5.1
16.6
52
105
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.1
16.6
52
105
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
16.5
217
1159
N03AX14
ATC
levetiracetam; systemic
5.3
16.5
50
97
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
16.5
308
1882
P01AB01
ATC
metronidazole; oral, rectal
1.7
16.4
461
3209
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
16.4
205
1073
A01
ICPC
Pain general/multiple sites
2.8
16.4
111
424
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
16.4
287
1714
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
16.4
249
1412
M48.0
ICD-10 Finland
Spinal stenosis
2.4
16.3
153
702
E000003
ATC
NA
3.5
16.3
77
229
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.5
16.3
77
229
R60.9
ICD-10 Finland
Oedema, unspecified
3.6
16.3
76
224
M79.6
ICD-10 Finland
Pain in limb
1.7
16.2
416
2816
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.2
16.2
50
99
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.0
16.2
52
108
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
16.1
366
2385
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
6.6
16.1
41
64
J01FA15
ATC
telithromycin; oral
2.5
16.0
135
586
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
15.9
80
250
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
15.9
119
484
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
15.9
85
279
E000002
ATC
NA
2.3
15.8
154
718
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
5.9
15.8
44
77
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
33.9
15.8
20
6
E24.8
ICD-10 Finland
Other Cushing syndrome
+∞
15.7
15
*
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
+∞
15.7
15
*
E25.01
ICD-10 Finland
Congenital adrenal hyperplasia
+∞
15.7
15
*
J01CA04
ATC
amoxicillin; systemic
1.8
15.7
925
7948
A07EC02
ATC
mesalazine; oral, rectal
3.2
15.6
85
283
E86
ICD-10 Finland
Volume depletion
5.0
15.5
50
104
H26.3
ICD-10 Finland
Drug-induced cataract
14.0
15.5
26
19
XQ800
NOMESCO Finland
Prick test
2.6
15.4
117
480
L04AD01
ATC
ciclosporin; systemic
5.8
15.4
43
76
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.9
15.3
97
355
JN4AD
NOMESCO Finland
Body CT examination
2.8
15.3
105
404
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.2
15.3
58
143
49300
ICD-8 Finland
Asthma, bronchiale
5.0
15.2
49
102
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
15.2
265
1574
G43.9
ICD-10 Finland
Migraine, unspecified
3.0
15.2
91
320
R01AD12
ATC
fluticasone furoate; nasal
1.8
15.2
350
2279
B01AA03
ATC
warfarin; systemic
2.0
15.2
211
1150
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
15.2
251
1461
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.0
15.0
60
155
R4180
NOMESCO Finland
Podiatric therapy
9.6
15.0
30
32
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.9
15.0
49
104
M05BB03
ATC
alendronic acid and colecalciferol; oral
5.5
14.9
44
83
N30.0
ICD-10 Finland
Acute cystitis
2.1
14.9
176
896
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.2
14.9
57
142
A07DA03
ATC
loperamide; oral
4.1
14.9
58
147
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.8
14.9
63
172
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
14.9
63
172
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
32.2
14.8
19
6
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.3
14.8
39
64
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.8
14.8
297
1850
M05BA07
ATC
risedronic acid; oral
4.1
14.8
58
148
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
4.3
14.7
54
129
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
14.7
84
288
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
14.7
56
139
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
14.6
67
195
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
14.6
91
331
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.2
14.6
77
250
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
14.6
112
462
SPAT1211
SPAT
Application of soft bandage
2.5
14.6
123
533
J01DA01
ATC
[U] cefalexin; systemic
1.6
14.6
690
5492
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
14.5
78
257
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
14.5
107
430
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
151.8
14.5
15
*
N02AC04
ATC
dextropropoxyphene; oral
3.8
14.5
61
166
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.1
14.5
57
146
R60.1
ICD-10 Finland
Generalized oedema
15.6
14.4
23
15
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
14.4
88
316
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
14.4
135
619
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
5.6
14.3
41
75
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
14.3
379
2569
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
14.3
102
401
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.8
14.3
40
71
C07AB02
ATC
metoprolol; systemic
1.9
14.3
224
1275
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
14.2
66
195
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
14.1
165
836
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
12.1
14.1
25
21
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.4
14.1
128
577
G44.2
ICD-10 Finland
Tension-type headache
2.1
13.9
166
850
E22.1
ICD-10 Finland
Hyperprolactinaemia
54.0
13.8
16
*
Z00.0
ICD-10 Finland
General medical examination
1.9
13.8
221
1269
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
13.8
260
1581
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
13.8
186
999
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
9.2
13.8
28
31
E66.01
ICD-10 Finland
Obesity due to excess calories
2.5
13.7
108
450
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
13.6
174
916
X58
ICD-10 Finland
Exposure to other specified factors
2.1
13.6
165
848
Z71.8
ICD-10 Finland
Other specified counselling
1.8
13.6
290
1834
E23.05
ICD-10 Finland
Lack of TSH
+∞
13.6
13
*
C10AC01
ATC
colestyramine; oral
4.3
13.5
50
121
WX002
NOMESCO Finland
Sedation and analgesia
1.9
13.5
230
1349
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.1
13.4
76
258
R06AX13
ATC
loratadine; oral
2.0
13.4
191
1047
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
13.4
126
576
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
13.4
68
215
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.3
13.4
68
215
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
13.4
97
385
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
13.4
149
737
SPAT1097
SPAT
Recording of ECG
2.1
13.4
172
908
C08CA01
ATC
amlodipine; oral
1.7
13.4
361
2448
A04AA01
ATC
ondansetron; systemic, rectal
2.7
13.3
94
369
N03AX11
ATC
topiramate; oral
4.5
13.3
47
109
R03BC03
ATC
nedocromil; inhalant
2.6
13.3
100
408
A04
ICPC
Weakness/tiredness general
2.1
13.2
162
836
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
13.2
226
1329
D02AE01
ATC
carbamide; topical
2.7
13.2
92
358
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.6
13.1
33
51
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
13.1
187
1026
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
13.1
89
342
A01AB04
ATC
amphotericin B; local oral
3.0
13.0
75
260
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
22.8
12.9
18
8
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
12.9
130
616
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.8
12.9
54
147
WX882
NOMESCO Finland
High dependency care
3.9
12.8
52
137
T89
ICPC
Diabetes insulin dependent
3.4
12.8
61
184
R41.0
ICD-10 Finland
Disorientation, unspecified
4.3
12.8
47
113
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
12.8
132
633
J32.4
ICD-10 Finland
Chronic pansinusitis
6.1
12.8
34
57
J01EA01
ATC
trimethoprim; systemic
1.7
12.8
289
1858
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.9
12.7
77
274
SPAT1216
SPAT
Assessment of functional ability
2.0
12.7
176
955
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
12.7
99
411
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
12.6
83
313
E000006
ATC
NA
2.6
12.6
96
393
K59.0
ICD-10 Finland
Constipation
3.0
12.5
74
261
E66.8
ICD-10 Finland
Other obesity
2.9
12.5
77
278
E21.0
ICD-10 Finland
Primary hyperparathyroidism
+∞
12.5
12
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
12.5
38
75
RJ410
NOMESCO Finland
NA
24.6
12.5
17
7
L04AB04
ATC
adalimumab; parenteral
5.5
12.5
36
67
R81
ICPC
Pneumonia
4.0
12.5
49
126
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.2
12.4
65
211
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.2
12.4
46
112
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
12.4
574
4462
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
12.3
92
374
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.2
12.3
46
113
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
12.3
139
692
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.5
12.3
97
406
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
9.1
12.3
25
28
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
12.2
75
270
A12BA01
ATC
potassium chloride; oral
3.4
12.2
58
175
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
12.2
108
481
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.4
12.2
36
69
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
16.1
12.2
19
12
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.0
12.2
48
124
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.0
12.2
48
124
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.5
12.2
56
165
N06AB05
ATC
paroxetine; oral
2.7
12.1
84
328
L17
ICPC
Foot/toe symptom/complaint
1.7
12.1
283
1834
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
12.1
140
706
R01AD05
ATC
budesonide; nasal
2.3
12.1
110
497
B37.08
ICD-10 Finland
Other candidal stomatitis
8.8
12.0
25
29
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
12.0
44
106
N03AF01
ATC
carbamazepine; oral, rectal
3.0
12.0
70
245
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
5.6
12.0
34
62
R05
ICD-10 Finland
Cough
1.8
12.0
219
1312
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
11.9
71
252
A07EA02
ATC
hydrocortisone; rectal
4.5
11.9
41
93
K50.1
ICD-10 Finland
Crohn disease of large intestine
7.1
11.8
28
40
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.1
11.8
67
228
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
9.8
11.8
23
24
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
9.8
11.8
23
24
L04AA01
ATC
[U] ciclosporin; systemic
5.1
11.8
36
72
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
11.7
158
848
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
11.7
187
1068
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
11.7
68
237
UDM02
NOMESCO Finland
Sinoscopy
4.3
11.7
43
104
D07AD01
ATC
clobetasol; topical
1.9
11.7
176
984
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.2
11.7
61
198
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
11.7
104
462
R42
ICD-10 Finland
Dizziness and giddiness
1.8
11.7
237
1466
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.3
11.6
42
100
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.6
11.6
51
145
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
23.1
11.6
16
7
WW200
NOMESCO Finland
Immunization
3.8
11.6
48
130
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
11.6
162
881
WX402
NOMESCO Finland
General anaesthesia
1.9
11.5
194
1131
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
11.5
75
281
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
11.5
11
*
E31.08
ICD-10 Finland
Autoimmune polyglandular failure
+∞
11.5
11
*
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
5.1
11.4
35
70
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.1
11.4
35
70
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
121.2
11.4
12
*
JN4CD
NOMESCO Finland
Very extensive body CT
3.5
11.4
52
152
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
6.1
11.4
30
50
A03FA02
ATC
cisapride; oral, rectal
2.4
11.4
100
443
N05CF02
ATC
zolpidem; oral
1.8
11.4
203
1206
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
8.4
11.3
24
29
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.6
11.3
51
148
V03AE01
ATC
polystyrene sulfonate; oral
10.7
11.3
21
20
N05BA06
ATC
lorazepam; systemic, sublingual
2.9
11.3
69
247
WX213
NOMESCO Finland
Lower leg blockade
9.0
11.3
23
26
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
6.3
11.3
29
47
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
6.3
11.3
29
47
L95
ICPC
Osteoporosis
3.6
11.2
50
144
RS222
NOMESCO Finland
NA
6.9
11.2
27
40
SBB10
NOMESCO Finland
Teeth copy
2.5
11.2
88
369
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
11.2
101
453
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.8
11.2
46
124
E83.51
ICD-10 Finland
Hypocalcemia
12.9
11.2
19
15
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
20.3
11.1
16
8
I95.9
ICD-10 Finland
Hypotension, unspecified
5.9
11.1
30
52
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
11.3
11.1
20
18
N04BC05
ATC
pramipexole; oral
2.5
11.1
89
375
M01AB55
ATC
diclofenac, combinations; oral
2.5
11.0
87
365
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.4
11.0
53
162
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
7.5
11.0
25
34
T78.4
ICD-10 Finland
Allergy, unspecified
3.0
11.0
63
218
L04AB01
ATC
etanercept; parenteral
5.6
10.9
31
57
R06AX22
ATC
ebastine; oral
1.8
10.9
204
1229
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
7.9
10.9
24
31
M01AH02
ATC
rofecoxib; oral
2.0
10.9
151
816
WX110
NOMESCO Finland
Local anesthesy
1.5
10.9
755
6362
TK800
NOMESCO Finland
Hemodialysis
5.0
10.9
34
70
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.4
10.9
38
88
UKC02
NOMESCO Finland
Cystoscopy
1.9
10.8
164
920
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.3
10.8
53
165
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.2
10.8
28
46
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
10.8
145
777
T99
ICPC
Endocr/metab/nutrit disease other
5.9
10.8
29
50
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
3.8
10.8
44
118
UJF92
NOMESCO Finland
Capsular endoscopy
4.4
10.7
38
89
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
28.3
10.7
14
5
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
28.3
10.7
14
5
L16
ICPC
Ankle symptom/complaint
2.1
10.7
120
597
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.6
10.7
47
134
D72.1
ICD-10 Finland
Eosinophilia
21.7
10.7
15
7
L86
ICPC
Back syndrome with radiating pain
2.6
10.7
75
295
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.7
10.7
45
124
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
10.7
78
314
N05AA02
ATC
levomepromazine; systemic
3.1
10.6
57
189
E28.3
ICD-10 Finland
Primary ovarian failure
60.6
10.6
12
*
A03CA02
ATC
clidinium and psycholeptics; oral
2.6
10.6
77
306
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
4.3
10.6
38
90
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.3
10.6
38
90
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
5.4
10.6
31
59
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.5
10.6
48
140
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.1
10.6
28
47
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.2
10.6
39
95
D07AC13
ATC
mometasone; topical
1.6
10.6
320
2213
C09CA01
ATC
losartan; oral
1.7
10.6
247
1590
R52.9
ICD-10 Finland
Pain, unspecified
2.2
10.6
107
507
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
10.6
80
327
-50
ICPC
Medication/prescr/renewal
3.0
10.5
61
213
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
10.5
87
375
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.5
10.5
36
82
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
10.5
122
614
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
10.5
399
2921
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
10.4
73
286
3028
Kela drug reimbursment
Mepolizumab
111.0
10.4
11
*
V04CD01
ATC
metyrapone; oral
+∞
10.4
10
*
E27
ICD-10 Finland
Other disorders of adrenal gland
+∞
10.4
10
*
301
Kela drug reimbursment
Growth hormone
+∞
10.4
10
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
10.4
10
*
E24.2
ICD-10 Finland
Drug-induced Cushing syndrome
+∞
10.4
10
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.9
10.4
33
69
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.8
10.4
23
30
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
3.4
10.4
49
148
E10
ICD-10 Finland
Type 1 diabetes mellitus
5.0
10.4
32
65
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
16.2
10.4
16
10
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.3
204
1250
K07.60
ICD-10 Finland
Snapping jaw
2.7
10.2
71
275
UJD02
NOMESCO Finland
Gastroscopy
2.9
10.2
63
227
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
10.2
81
339
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
10.2
98
454
UDC00
NOMESCO Finland
Ear microscopy
2.4
10.2
90
400
C09CA06
ATC
candesartan; oral
1.7
10.2
229
1458
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
8.0
10.1
22
28
Z02.7
ICD-10 Finland
Issue of medical certificate
2.6
10.1
72
286
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.0
10.1
24
35
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.7
10.1
234
1502
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.2
10.1
52
168
R06AX27
ATC
desloratadine; oral
1.6
10.0
301
2071
SPAT1252
SPAT
Overall medication plan or its review
2.4
10.0
81
345
XX1VW
NOMESCO Finland
Written report from radiologist
10.1
10.0
19
19
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
14.7
10.0
16
11
H26.2
ICD-10 Finland
Complicated cataract
5.9
10.0
27
47
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.8
10.0
63
233
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.9
10.0
59
210
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.2
10.0
52
170
L88
ICPC
Rheumatoid/seropositive arthritis
3.1
9.9
53
176
A01AB10
ATC
natamycin; local oral
3.6
9.9
43
122
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
9.9
59
211
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
16.9
9.9
15
9
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
9.9
80
1514
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
9.9
424
3184
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.5
9.8
28
52
L03
ICPC
Low back symptom/complaint
1.6
9.8
267
1789
R49.08
ICD-10 Finland
Other specified dysphonia
4.2
9.8
36
88
N06AB10
ATC
escitalopram; oral
1.7
9.8
228
1464
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
9.8
176
1044
D07AB08
ATC
desonide; topical
2.0
9.7
125
654
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.4
9.7
85
377
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.5
9.7
44
129
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
9.7
169
992
J37.0
ICD-10 Finland
Chronic laryngitis
3.6
9.7
43
124
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
9.7
284
1940
C08DA01
ATC
verapamil; systemic
2.9
9.7
58
208
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.9
9.7
26
45
K76.9
ICD-10 Finland
Liver disease, unspecified
5.6
9.7
27
49
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.6
9.7
72
293
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.5
9.6
44
130
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.9
9.6
30
62
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.4
9.6
33
76
A02BC04
ATC
rabeprazole; oral
2.2
9.6
100
480
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.3
9.5
46
142
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
9.5
55
192
M03BX01
ATC
baclofen; systemic
4.9
9.5
30
63
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.2
9.5
35
86
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.7
9.5
40
111
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.6
9.5
70
282
N03AF02
ATC
oxcarbazepine; oral
3.3
9.5
46
143
R01AC01
ATC
cromoglicic acid; nasal
3.0
9.4
52
177
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
100.8
9.4
10
*
297
Kela drug reimbursment
NA
100.8
9.4
10
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
9.4
202
1267
RJ421
NOMESCO Finland
NA
30.3
9.4
12
*
L29
ICPC
Musculoskeletal sympt/complt other
2.2
9.4
92
429
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
9.4
27
51
E25.0
ICD-10 Finland
Congenital adrenogenital disorders associated with enzyme deficiency
+∞
9.4
9
*
L01XX23
ATC
mitotane; oral
+∞
9.4
9
*
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
9.4
9
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.5
9.4
32
73
RJ411
NOMESCO Finland
NA
21.9
9.4
13
6
D84.18
ICD-10 Finland
Other specified defect in the complement system
21.9
9.4
13
6
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.0
9.3
53
182
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
9.3
124
661
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
10.8
9.3
17
16
K65.0
ICD-10 Finland
Acute peritonitis
6.5
9.3
23
36
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
9.3
32
74
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.4
9.3
32
74
N19
ICD-10 Finland
Unspecified kidney failure
3.5
9.2
42
124
N04BC06
ATC
cabergoline; oral (dopamine agonists)
13.8
9.2
15
11
A02BX02
ATC
sucralfate; oral
2.9
9.2
55
198
M43.1
ICD-10 Finland
Spondylolisthesis
2.9
9.2
54
192
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
9.2
65
257
J01CA08
ATC
pivmecillinam; oral
1.5
9.1
443
3400
D02AX
ATC
Other emollients and protectives
3.1
9.1
49
164
L99
ICPC
Musculoskeletal disease other
4.6
9.1
30
66
B81
ICPC
Anaemia vit B12/folate deficiency
3.0
9.1
50
170
J30.3
ICD-10 Finland
Other allergic rhinitis
3.0
9.1
50
170
A10AA01
ATC
NA
3.6
9.1
39
110
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.6
9.1
39
110
NDG76
NOMESCO Finland
Fusion of DIP joint
8.4
9.1
19
23
J96.0
ICD-10 Finland
Acute respiratory failure
5.7
9.1
25
45
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.5
9.0
41
121
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
10.1
9.0
17
17
BC1AD
NOMESCO Finland
CT of adrenal glands
10.1
9.0
17
17
A10AE06
ATC
insulin degludec; parenteral
3.5
9.0
40
116
N06AB03
ATC
fluoxetine; oral
1.9
9.0
142
803
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
9.0
282
1958
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
9.0
94
454
A29
ICPC
General symptom/complaint other
2.0
8.9
123
662
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.3
8.9
26
50
K51.8
ICD-10 Finland
Other ulcerative colitis
5.3
8.9
26
50
J01XX08
ATC
linezolid; systemic
18.8
8.9
13
7
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.7
8.9
60
230
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
24.2
8.9
12
5
J05AB01
ATC
aciclovir; systemic
1.6
8.9
227
1495
R07.3
ICD-10 Finland
Other chest pain
2.1
8.9
103
521
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.5
8.9
65
264
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.4
8.8
76
335
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.8
232
1539
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
8.7
8.8
18
21
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
8.8
76
336
S19
ICPC
Skin injury other
3.0
8.8
50
172
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.1
8.8
33
83
G62.8
ICD-10 Finland
Other specified polyneuropathies
9.6
8.8
17
18
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
7.2
8.7
20
28
R52.1
ICD-10 Finland
Chronic intractable pain
7.2
8.7
20
28
I45.9
ICD-10 Finland
Conduction disorder, unspecified
7.2
8.7
20
28
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
8.7
241
1616
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
8.7
39
114
A41.8
ICD-10 Finland
Other specified sepsis
4.5
8.7
29
65
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.5
8.7
29
65
A02BA03
ATC
famotidine; systemic
2.8
8.7
55
204
RJ190
NOMESCO Finland
NA
50.4
8.7
10
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
8.7
115
610
C07AA05
ATC
propranolol; systemic
1.7
8.7
207
1334
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.9
8.7
50
175
-1
NOMESCO Finland
NA
1.5
8.6
357
2641
A02BA04
ATC
nizatidine; systemic
2.2
8.6
87
413
M79.1
ICD-10 Finland
Myalgia
1.8
8.6
144
833
ZX112
NOMESCO Finland
Subcutaneous
3.8
8.6
35
95
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
8.6
303
2163
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
16.4
8.6
13
8
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.3
8.6
74
327
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
8.5
26
53
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
8.5
81
373
M05BA06
ATC
ibandronic acid; systemic
4.2
8.5
31
76
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.5
8.5
21
33
NDG71
NOMESCO Finland
Arthrodes of first MP joint
27.7
8.5
11
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.0
8.5
22
37
K29.7
ICD-10 Finland
Gastritis, unspecified
2.9
8.5
49
172
E83.50
ICD-10 Finland
Hypercalcemia
7.4
8.5
19
26
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.5
8.4
38
112
WX723
NOMESCO Finland
CPAP therapy
3.1
8.4
44
145
R03DX09
ATC
mepolizumab; parenteral
90.7
8.4
9
*
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.7
8.4
35
97
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.8
8.4
34
92
PAW37
NOMESCO Finland
Biopsy of temporal artery
6.8
8.4
20
30
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.8
8.4
20
30
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
6.8
8.4
20
30
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.9
8.4
33
87
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.0
8.4
48
167
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.8
8.4
53
197
2554X
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[HYPOFUNCTIO CORTICOADRENALIS ALIA]
+∞
8.3
8
*
E23.06
ICD-10 Finland
Empty sella
+∞
8.3
8
*
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.3
8.3
21
34
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
8.6
8.3
17
20
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.2
8.3
30
73
XKD00
NOMESCO Finland
Uroflowmetry
1.8
8.3
138
795
XQ802
NOMESCO Finland
Epicutan test
2.7
8.3
56
215
XQ820
NOMESCO Finland
Exposure to medicinal substance
9.5
8.3
16
17
107
Kela drug reimbursment
Pernicious anaemia
3.9
8.3
32
83
B03XA02
ATC
darbepoetin alfa; parenteral
4.5
8.3
28
64
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
8.3
42
136
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.9
8.2
127
714
B01AB10
ATC
tinzaparin; parenteral
2.2
8.2
85
410
ZZA00
NOMESCO Finland
Split skin graft
3.2
8.2
41
131
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
8.2
71
312
ZX198
NOMESCO Finland
Other local administration
6.1
8.2
21
35
G72.9
ICD-10 Finland
Myopathy, unspecified
6.1
8.2
21
35
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
5.4
8.2
23
43
M04AA01
ATC
allopurinol; systemic
1.9
8.1
119
657
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
8.1
84
404
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
33.6
8.1
10
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.5
8.1
27
61
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.3
8.1
39
122
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.1
8.0
24
48
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.1
8.0
24
48
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
5.1
8.0
24
48
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.0
8.0
110
591
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.2
8.0
76
352
G43.3
ICD-10 Finland
Complicated migraine
4.2
8.0
29
71
R05CB01
ATC
acetylcysteine; inhalant, oral
5.6
8.0
22
40
N06AX26
ATC
vortioxetine; oral
2.4
8.0
68
299
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
7.3
8.0
18
25
N05BA12
ATC
alprazolam; oral
1.9
7.9
121
679
R04.0
ICD-10 Finland
Epistaxis
2.2
7.9
78
368
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
7.9
72
325
H3601, E103
ICD-10 Finland
NA
6.6
7.9
19
29
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
7.9
87
431
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
7.9
62
263
R49.01
ICD-10 Finland
Functional dysphonia
2.9
7.8
46
164
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.1
7.8
41
136
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
7.8
225
1524
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.4
7.8
64
276
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
8.5
7.8
16
19
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.2
7.8
28
68
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
9.5
7.8
15
16
SPAT1104
SPAT
Monitoring of emergency patient
2.2
7.8
77
364
K08.3
ICD-10 Finland
Retained dental root
2.2
7.8
79
377
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.1
7.8
92
467
K90.0
ICD-10 Finland
Coeliac disease
3.1
7.8
41
137
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.7
282
2018
M35.7
ICD-10 Finland
Hypermobility syndrome
4.3
7.7
27
64
D01AE16
ATC
amorolfine; topical
1.9
7.7
119
668
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
15.1
7.7
12
8
120
Kela drug reimbursment
Hypogammaglobulinaemia
15.1
7.7
12
8
R05
ICPC
Cough
1.6
7.7
232
1586
K50.8
ICD-10 Finland
Other Crohn disease
4.6
7.7
25
55
R03BC01
ATC
cromoglicic acid; inhalant
4.1
7.7
28
69
I50.0
ICD-10 Finland
Congestive heart failure
2.3
7.7
71
324
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
7.5
7.7
17
23
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
7.7
51
197
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
7.6
34
100
F32.1
ICD-10 Finland
Moderate depressive episode
2.4
7.6
63
274
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.7
7.6
49
185
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
18.5
7.6
11
6
A11CC02
ATC
dihydrotachysterol; oral
18.5
7.6
11
6
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.8
7.6
46
168
127
Kela drug reimbursment
Transplant complication
4.5
7.6
25
56
TGD00
NOMESCO Finland
Needle biopsy of lung
11.9
7.6
13
11
Z56.5
ICD-10 Finland
Uncongenial work
25.2
7.6
10
*
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.6
7.6
52
203
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
7.6
183
1184
N06AA10
ATC
nortriptyline; systemic
3.4
7.6
34
101
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.9
7.6
15
17
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
7.5
60
256
Z49.2
ICD-10 Finland
Other dialysis
10.1
7.5
14
14
S29
ICPC
Skin symptom/complaint other
1.7
7.5
178
1141
R52.0
ICD-10 Finland
Acute pain
2.9
7.5
44
157
XA402
NOMESCO Finland
ENMG
3.2
7.5
37
118
G04BD12
ATC
mirabegron; oral
1.9
7.5
102
547
R01AD11
ATC
triamcinolone; nasal
1.9
7.5
102
548
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.9
7.5
23
48
L14
ICPC
Leg/thigh symptom/complaint
2.1
7.5
82
407
R30.0
ICD-10 Finland
Dysuria
2.8
7.4
47
174
E20.8
ICD-10 Finland
Other hypoparathyroidism
80.6
7.4
8
*
2533
FHL
Unilateral removal of additional egg
80.6
7.4
8
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
7.4
72
338
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
4.1
7.4
27
67
SPAT1125
SPAT
Stoma care and guidance
5.3
7.4
21
40
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
5.6
7.4
20
36
S01
ICPC
Pain/tenderness of skin
2.5
7.4
54
218
RD211
NOMESCO Finland
NA
2.4
7.4
58
246
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.4
250
1760
N05BE01
ATC
buspirone; oral
2.9
7.4
42
146
B01AF02
ATC
apixaban; oral
2.0
7.3
95
500
L01
ICPC
Neck symptom/complaint
1.7
7.3
150
925
137
Kela drug reimbursment
Uraemia requiring dialysis
8.4
7.3
15
18
R33
ICD-10 Finland
Retention of urine
2.2
7.3
73
344
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.9
7.3
17
25
25800
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Cushing's syndrome
+∞
7.3
7
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
7.3
7
*
3027
Kela drug reimbursment
Benralizumab
+∞
7.3
7
*
E31.0
ICD-10 Finland
Autoimmune polyglandular failure
+∞
7.3
7
*
E24.3
ICD-10 Finland
Ectopic ACTH syndrome
+∞
7.3
7
*
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
7.3
7
*
X57
ICD-10 Finland
Unspecified privation
3.7
7.3
30
83
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.2
7.3
36
115
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
9.4
7.3
14
15
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
9.4
7.3
14
15
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.0
7.3
39
132
A10AA02
ATC
NA
3.0
7.3
40
138
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.2
7.3
21
41
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
7.2
104
569
A44
ICPC
General and Unspecified, Preventive immunization/medic
2.1
7.2
84
424
W19
ICD-10 Finland
Unspecified fall
1.9
7.2
102
554
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
5.5
7.2
20
37
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
15.9
7.2
11
7
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
15.9
7.2
11
7
R4190
NOMESCO Finland
Nutritional therapy
2.6
7.2
48
186
R06.2
ICD-10 Finland
Wheezing
2.5
7.2
54
223
205
Kela drug reimbursment
Chronic hypertension
1.5
7.2
247
1743
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.0
7.2
27
69
S22.3
ICD-10 Finland
Fracture of rib
2.2
7.2
70
328
-44
ICPC
Preventive immunization/medic
1.9
7.2
96
513
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
7.2
46
173
I95.1
ICD-10 Finland
Orthostatic hypotension
2.9
7.2
42
150
SBA00
NOMESCO Finland
Microbiological examinations
3.2
7.2
35
111
WX204
NOMESCO Finland
Axillary plexus blockaced
3.0
7.2
38
128
J20
ICD-10 Finland
Acute bronchitis
1.9
7.1
109
611
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
7.1
39
134
B35.3
ICD-10 Finland
Tinea pedis
2.7
7.1
47
181
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.6
7.1
50
199
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
8.0
7.1
15
19
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.1
7.1
26
65
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
4.1
7.1
26
65
L29.9
ICD-10 Finland
Pruritus, unspecified
3.3
7.1
33
101
M02AA10
ATC
ketoprofen; topical
1.7
7.1
165
1056
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
3.8
7.1
28
75
T90
ICPC
Diabetes non-insulin dependent
1.6
7.1
210
1428
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
6.1
7.1
18
30
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
7.1
64
289
G44.0
ICD-10 Finland
Cluster headache syndrome
5.7
7.1
19
34
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
7.1
89
465
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
7.1
172
1112
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.8
7.1
14
16
M05BA01
ATC
etidronic acid; systemic
8.8
7.1
14
16
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.4
7.0
24
56
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
7.0
78
385
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
7.0
93
496
SPAT1131
SPAT
Colonoscopy
2.8
7.0
43
159
F05.9
ICD-10 Finland
Delirium, unspecified
4.2
7.0
25
61
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.2
7.0
25
61
N06AB06
ATC
sertraline; oral
1.8
7.0
122
714
L60.0
ICD-10 Finland
Ingrowing nail
2.5
7.0
53
221
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.0
7.0
21
43
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
4.5
7.0
23
52
C08CA02
ATC
felodipine; oral
2.0
7.0
87
455
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
7.0
231
1615
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
7.0
73
353
R09
ICPC
Sinus symptom/complaint
2.0
7.0
88
459
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
5.2
6.9
20
39
K51.5
ICD-10 Finland
Left sided colitis
3.1
6.9
35
114
K30
ICD-10 Finland
Functional dyspepsia
1.8
6.9
116
670
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.8
6.9
123
726
L30.3
ICD-10 Finland
Infective dermatitis
2.7
6.9
44
164
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.7
6.9
28
77
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
3.9
6.9
26
67
T82
ICPC
Obesity
2.6
6.9
48
190
J01FA01
ATC
erythromycin; systemic
1.7
6.9
152
959
N02CC03
ATC
zolmitriptan; nasal, oral
2.2
6.9
65
300
R15
ICD-10 Finland
Faecal incontinence
3.2
6.9
33
104
C08CA13
ATC
lercanidipine; oral
1.8
6.8
124
736
XG405
NOMESCO Finland
Education on PEF monitoring
4.2
6.8
24
58
L52
ICD-10 Finland
Erythema nodosum
6.7
6.8
16
24
N07BC02
ATC
methadone; systemic
11.0
6.8
12
11
RS142
NOMESCO Finland
NA
11.0
6.8
12
11
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.8
6.8
27
73
R00.2
ICD-10 Finland
Palpitations
2.1
6.8
77
388
RD210
NOMESCO Finland
NA
3.4
6.8
31
94
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
6.8
70
339
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.9
6.7
39
138
R04
ICPC
Breathing problem other
2.8
6.7
40
145
N18.8
ICD-10 Finland
Other chronic renal failure
3.5
6.7
29
84
SPAT1240
SPAT
Therapeutic discussion
1.8
6.7
118
695
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.1
6.7
24
59
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
7.2
6.7
15
21
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
7.2
6.7
15
21
R4120
NOMESCO Finland
Occupational therapy
2.1
6.7
69
332
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.8
6.7
26
69
H53.4
ICD-10 Finland
Visual field defects
3.8
6.7
26
69
S06.0
ICD-10 Finland
Concussion
1.8
6.7
109
626
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.2
6.7
67
320
M45
ICD-10 Finland
Ankylosing spondylitis
3.4
6.7
30
90
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.7
6.7
43
163
R03BB07
ATC
umeclidinium bromide; inhalant
6.5
6.6
16
25
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
6.5
6.6
16
25
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
5.2
6.6
19
37
D07XC01
ATC
betamethasone, combinations; topical
1.8
6.6
117
689
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
5.5
6.6
18
33
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
5.5
6.6
18
33
R13
ICD-10 Finland
Dysphagia
2.1
6.6
71
349
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.1
6.6
34
113
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.3
6.6
58
259
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
6.6
68
328
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
6.6
133
815
S41.1
ICD-10 Finland
Open wound of upper arm
8.7
6.6
13
15
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
4.8
6.5
20
42
N06AG02
ATC
moclobemide; oral
2.4
6.5
53
229
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
6.5
42
158
B03XA01
ATC
erythropoietin; parenteral
6.9
6.5
15
22
K20
ICD-10 Finland
Oesophagitis
4.2
6.5
23
56
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.6
6.5
27
76
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
6.5
56
250
WX730
NOMESCO Finland
Conventional respirator
4.0
6.5
24
61
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.0
6.5
24
61
N29
ICPC
Neurological sympt/complt other
3.7
6.5
26
71
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
3.2
6.5
32
103
J01MA01
ATC
ofloxacin; systemic
1.9
6.5
85
453
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
6.4
57
255
A12AA06
ATC
calcium lactate gluconate; oral
70.2
6.4
7
*
RJ425
NOMESCO Finland
NA
70.2
6.4
7
*
R89.1
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal level of hormones
70.2
6.4
7
*
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
70.2
6.4
7
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.5
6.4
49
205
J02AC02
ATC
itraconazole; systemic
1.6
6.4
186
1256
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.2
6.4
60
278
RS221
NOMESCO Finland
NA
3.8
6.4
25
67
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
6.4
43
169
J01DA06
ATC
[U] cefuroxime; systemic
1.7
6.4
147
935
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.4
6.4
21
48
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
6.4
99
560
M54.2
ICD-10 Finland
Cervicalgia
2.1
6.3
71
354
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.6
6.3
42
163
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.3
565
4753
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
8.2
6.3
13
16
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
8.2
6.3
13
16
N18.0
ICD-10 Finland
End-stage renal disease
5.2
6.3
18
35
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
4.2
6.3
22
53
B01AC04
ATC
clopidogrel; oral
1.7
6.3
134
833
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.1
6.3
67
329
J05AH02
ATC
oseltamivir; oral
6.0
6.3
16
27
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.0
6.3
16
27
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.5
6.3
17
31
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.6
6.3
26
73
ZXC86
NOMESCO Finland
Use of endoscopic device
11.1
6.3
11
10
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
11.1
6.3
11
10
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
11.1
6.3
11
10
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
6.3
111
655
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.7
6.3
25
68
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.4
6.3
51
220
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.0
6.3
34
117
197
Kela drug reimbursment
Sunitinib
9.3
6.3
12
13
NXL00
NOMESCO Finland
Biopsy of muscle
9.3
6.3
12
13
SPAT1059
SPAT
Spirometry at the office
2.3
6.3
56
251
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
18.1
6.3
9
5
E25.9
ICD-10 Finland
Adrenogenital disorder, unspecified
+∞
6.3
6
*
2581B
ICD-9 Finland
Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]
+∞
6.3
6
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
6.3
6
*
E31.01
ICD-10 Finland
Schmidt's syndrome
+∞
6.3
6
*
2552A
ICD-9 Finland
Disorders of adrenal glands, Adrenogenital disorders[SYNDROMA ADRENOGENITALE CONGENITUM]
+∞
6.3
6
*
BCA40
NOMESCO Finland
Bilateral adrenalectomy
+∞
6.3
6
*
251
Kela drug reimbursment
NA
+∞
6.3
6
*
2550X
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]
+∞
6.3
6
*
E23.3
ICD-10 Finland
Hypothalamic dysfunction, not elsewhere classified
+∞
6.3
6
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
6.3
6
*
R03DX10
ATC
benralizumab; systemic
+∞
6.3
6
*
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
4.8
6.2
19
40
TEG00
NOMESCO Finland
Punction of mandibular joint
26.8
6.2
8
*
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
26.8
6.2
8
*
C01DA14
ATC
isosorbide mononitrate; oral
1.7
6.2
127
783
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.5
6.2
45
184
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.5
6.2
45
184
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
4.1
6.2
22
54
A10BH01
ATC
sitagliptin; oral
1.9
6.2
85
461
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.6
6.2
42
166
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.0
6.2
23
59
M01CB01
ATC
sodium aurothiomalate; parenteral
3.8
6.2
24
64
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
6.2
90
497
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.7
6.2
40
152
SPAT1139
SPAT
Nutrition survey
2.7
6.2
40
152
-55
ICPC
Local injection/infiltration
6.3
6.2
15
24
H3603, E103
ICD-10 Finland
NA
5.8
6.2
16
28
R06.4
ICD-10 Finland
Hyperventilation
3.4
6.1
27
80
XF404
NOMESCO Finland
Ambulatory ECG
1.8
6.1
99
567
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
6.1
108
638
M81.8
ICD-10 Finland
Other osteoporosis
7.7
6.1
13
17
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.7
6.1
13
17
XKC03
NOMESCO Finland
Water cystometry
2.7
6.1
38
143
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
12.6
6.1
10
8
JFH10
NOMESCO Finland
Total colectomy and ileostomy
12.6
6.1
10
8
C08CA05
ATC
nifedipine; systemic
2.1
6.1
65
320
J05AB11
ATC
valaciclovir; oral
1.7
6.1
135
852
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
6.1
31
103
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
8.6
6.1
12
14
Y0099
ICD-8 Finland
Investigation of endocrine system and metabolism
8.6
6.1
12
14
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
6.1
50
219
R51.81
ICD-10 Finland
Facial pain NOS
3.2
6.1
29
92
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
6.0
46
191
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.2
6.0
17
33
NF1DA
NOMESCO Finland
X-ray of hips
3.3
6.0
28
87

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3035637) Corticotropin [Mass/volume] in Plasma
415
100
60.47
307.65
2.8
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
369
114
44.79
307.65
4.6
1.2
mu/l
84.8
44.9
2.14
349
104
(3036481) Cortisol [Moles/volume] in Serum or Plasma
889
939
27.74
307.65
6.2
1.8
nmol/l
221.3
376.7
40.12
838
864
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
157
111
15.95
176.00
1.5
1.2
pmol/l
288.9
319.0
0.29
113
84
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1020
5093
5.64
162.92
13.7
6.4
mmol/l
1.2
1.2
1.48
797
4313
(3023368) Bacteria identified in Blood by Culture
700
2660
4.53
160.21
7.8
4.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
87
15
62.08
156.26
1.6
1.3
ug/l
1.5
1.1
0.36
82
15
(3017181) Myelocytes/100 leukocytes in Blood
365
852
5.56
153.59
6.3
4.0
%
0.9
1.0
0.28
132
253
(3002179) Metamyelocytes/100 leukocytes in Blood
347
776
5.73
153.19
5.8
4.0
%
0.5
0.6
0.65
110
183
(3025159) Blasts/100 leukocytes in Blood
337
755
5.67
148.11
6.5
4.2
%
0.0
0.5
0.62
119
193
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
907
4382
4.53
144.30
4.0
2.2
nmol/l
79.0
77.0
1.31
862
3933
(3012095) Magnesium [Moles/volume] in Serum or Plasma
505
1613
4.48
143.20
5.2
3.4
mmol/l
0.8
0.8
2.99
480
1520
(3021440) Promyelocytes/100 leukocytes in Blood
344
807
5.44
143.14
6.5
4.1
%
0.1
0.1
0.18
127
230
(3021387) Prolactin [Units/volume] in Serum or Plasma
222
344
7.58
141.26
2.4
1.3
mu/l
349.6
292.7
1.69
205
308
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
930
4627
4.54
140.67
13.1
5.9
mmol/l
1.2
1.2
2.06
898
4188
(3005719) IgG [Mass/volume] in Serum or Plasma
336
797
5.34
137.63
4.4
2.8
g/l
9.4
10.5
4.24
314
733
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
338
810
5.29
136.74
7.1
3.2
mmol/l
1.2
1.2
2.29
326
691
(3018418) pH of Serum or Plasma
711
2997
4.03
134.85
8.1
3.6
ph
7.4
7.4
0.41
277
553
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
294
641
5.63
132.19
3.8
3.3
pmol/l
4.3
4.5
3.43
270
568
(3009214) Lutropin [Units/volume] in Serum or Plasma
180
240
8.54
130.20
1.6
1.3
u/l
14.9
9.9
2.49
154
184
(3003458) Phosphate [Moles/volume] in Serum or Plasma
421
1278
4.39
125.68
7.5
5.7
mmol/l
1.0
1.1
0.27
406
1190
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
300
715
5.15
121.12
2.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
535
2003
3.84
117.59
4.2
2.7
mosm/kgh2o
489.1
546.2
7.59
490
1708
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
160
210
8.55
116.94
4.5
3.6
%
60.7
57.3
1.83
160
210
(1616796) Gas panel - Central venous blood
150
183
9.13
116.29
5.2
3.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
62
10
65.05
112.22
1.5
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
153
203
8.41
110.69
4.1
3.4
e9/l
4.9
4.3
1.92
153
203
(3003181) Sodium [Moles/volume] in Urine
141
171
9.13
109.70
1.7
1.4
mmol/l
71.9
64.6
0.89
126
145
(40767503) Oxygen content in Capillary blood by calculation
146
193
8.39
105.85
3.8
2.1
%
15.9
16.1
0.12
81
96
(3004789) Transferrin [Mass/volume] in Serum or Plasma
419
1417
3.89
105.36
3.2
2.4
g/l
2.3
2.4
1.17
388
1316
(3028026) IgM [Mass/volume] in Serum or Plasma
264
632
4.99
105.11
2.3
1.7
g/l
1.2
1.4
0.38
250
582
(3012501) Base excess in Blood by calculation
145
193
8.33
104.49
6.1
3.9
mmol/l
3.0
2.7
0.42
114
128
(3024561) Albumin [Mass/volume] in Serum or Plasma
835
4392
3.52
103.68
9.2
4.7
g/l
34.1
35.8
14.07
797
4082
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
398
1313
3.93
103.54
3.3
2.4
%
21.3
22.9
1.28
342
1120
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
452
1635
3.70
102.43
2.9
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
727
3565
3.36
100.34
11.4
6.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
589
2571
3.36
98.25
3.4
2.2
mg/l
3.2
3.0
1.68
544
2180
(3013826) Glucose [Moles/volume] in Serum or Plasma
1002
6054
3.85
96.64
10.1
4.7
mmol/l
6.7
6.6
0.62
975
5657
(3022948) Iron [Moles/volume] in Serum or Plasma
426
1546
3.61
95.11
3.4
2.4
umol/l
11.5
13.3
5.57
395
1427
(3001604) Monocytes [#/volume] in Blood
921
5341
3.48
93.44
12.1
5.9
e9/l
0.6
0.6
16.93
868
4630
(3006315) Basophils [#/volume] in Blood
923
5360
3.49
93.42
12.1
5.9
e9/l
0.0
0.0
0.69
870
4658
(40760892) CBC W Ordered Manual Differential panel - Blood
556
2418
3.27
92.08
10.5
4.4
—
—
—
0
0
(4062490)
101
99
10.98
91.69
1.8
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
939
5547
3.49
91.58
12.5
6.2
e9/l
0.2
0.2
0.76
885
4892
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
669
3252
3.18
91.28
4.6
2.4
u/l
53.8
57.0
0.55
634
2996
(3028192) IgG subclass 2 [Mass/volume] in Serum
99
97
10.96
89.88
1.7
1.4
g/l
2.4
2.7
0.94
47
68
(3027135) IgG subclass 1 [Mass/volume] in Serum
99
97
10.96
89.88
1.7
1.4
g/l
6.4
7.4
0.75
48
70
(3024139) IgG subclass 3 [Mass/volume] in Serum
99
97
10.96
89.88
1.7
1.4
g/l
0.4
0.4
0.17
47
68
(3010421) pH of Blood
148
240
6.83
89.07
6.3
3.6
ph
7.4
7.4
0.29
141
189
(3019198) Lymphocytes [#/volume] in Blood
928
5505
3.39
88.53
12.3
5.9
e9/l
2.0
1.9
0.15
879
4876
(3022096) Basophils/100 leukocytes in Blood
857
4856
3.24
88.41
12.6
6.0
%
0.6
0.7
4.13
837
4534
(3005322) IgE [Units/volume] in Serum or Plasma
262
713
4.35
87.81
2.3
1.2
u/ml
500.9
216.1
1.07
252
652
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
322
1018
3.87
87.66
6.1
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
914
5419
3.31
86.30
10.7
6.1
umol/l
9.3
11.2
11.39
881
5141
(3006504) Eosinophils/100 leukocytes in Blood
869
5013
3.21
85.89
12.7
5.9
%
2.5
2.9
4.56
848
4670
(3019069) Monocytes/100 leukocytes in Blood
869
5040
3.18
84.53
13.0
6.2
%
8.5
8.5
0.19
851
4718
(3024980) IgG subclass 4 [Mass/volume] in Serum
119
162
7.98
83.80
1.7
1.7
g/l
0.6
0.8
1.19
63
124
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
180
377
5.38
82.89
2.9
2.0
ug/l
1.8
2.0
0.08
165
342
(3032080) INR in Blood by Coagulation assay
739
4004
2.96
79.63
16.7
8.4
inr
1.2
1.2
0.45
342
1151
(3002030) Lymphocytes/100 leukocytes in Blood
874
5202
3.07
78.88
12.8
6.0
%
25.9
28.5
9.38
851
4849
(3008295) Osmolality of Serum or Plasma
94
106
9.48
76.95
1.6
1.3
mosm/kgh2o
272.6
280.9
1.96
77
80
(3013650) Neutrophils [#/volume] in Blood by Automated count
970
6211
3.21
75.02
16.4
9.1
e9/l
4.9
4.0
20.26
915
5445
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
608
3042
2.87
74.80
3.2
2.1
u/l
182.3
218.9
0.59
583
2867
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
136
241
6.19
74.71
2.0
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
280
890
3.73
74.68
6.8
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
856
5130
2.95
74.49
12.0
5.8
%
59.7
56.8
8.97
837
4810
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
137
246
6.11
74.24
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
320
1115
3.48
74.09
2.7
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
486
2166
2.99
74.01
2.1
1.5
g/l
2.3
2.3
0.06
350
1309
(3007853) Bacteria identified in Skin by Aerobe culture
338
1222
3.39
73.74
2.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
320
1131
3.43
72.27
2.7
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
146
288
5.58
71.57
1.6
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
662
3536
2.78
70.72
5.0
3.4
mmol/l
2.3
2.4
6.42
605
3105
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
225
643
4.02
69.65
5.8
4.0
mmol/l
2.2
1.8
0.78
175
488
(3021589) Normoblasts [#/volume] in Blood
797
4749
2.75
67.44
24.4
9.0
e9/l
0.0
0.0
0.04
731
3900
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1127
8116
3.91
67.10
16.8
7.2
u/l
78.4
78.2
0.05
1107
7632
(3015171) Extractable nuclear Ab [Units/volume] in Serum
174
421
4.62
67.04
1.4
1.2
u/ml
1.3
1.7
0.11
18
30
(3042936) Bacteria identified in Isolate by Culture
364
1447
3.10
67.03
3.3
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
368
1475
3.08
66.76
1.6
1.3
titre
485.3
533.8
0.22
76
311
(3009343) pH of Capillary blood
227
672
3.88
66.70
5.9
4.0
ph
7.4
7.4
1.19
63
71
(3021901) Oxygen saturation in Capillary blood
108
170
6.84
66.51
3.5
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
100
145
7.39
66.41
3.4
2.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
72
70
10.83
65.49
1.8
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
465
2143
2.82
65.05
4.0
2.5
e6/l
6.0
6.6
0.35
430
1886
(3016502) Oxygen saturation in Arterial blood
281
981
3.38
64.08
9.9
8.9
%
95.9
95.8
0.10
275
950
(3019060) Gas panel - Arterial blood
216
635
3.88
63.97
7.2
5.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
68
63
11.33
63.89
2.2
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
110
184
6.44
63.84
1.7
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
94
134
7.48
63.35
1.9
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
295
1069
3.28
63.22
4.6
4.5
u/l
264.7
254.6
0.18
280
1016
(3023419) Bacteria identified in Sputum by Culture
92
129
7.60
62.90
5.2
2.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
273
947
3.38
62.80
8.0
4.2
kpa
5.9
5.8
0.42
265
917
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
680
3839
2.62
62.67
6.7
3.4
ng/l
27.3
48.8
1.39
545
2539
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
134
277
5.28
62.15
2.7
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
97
147
7.05
61.83
1.7
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
780
4723
2.63
61.81
4.5
2.7
ug/l
136.1
113.2
1.97
737
4366
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
297
1095
3.22
61.72
9.9
8.4
kpa
4.9
5.1
4.17
289
1052
(3027801) Oxygen [Partial pressure] in Arterial blood
297
1096
3.22
61.61
9.8
8.4
kpa
11.7
12.4
1.84
285
1053
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
76
87
9.22
61.36
2.2
1.2
u/ml
1.5
0.9
0.34
44
37
(3003396) Base excess in Arterial blood by calculation
297
1101
3.20
61.10
9.9
8.4
mmol/l
1.1
1.1
0.09
243
876
(3017446) Testosterone [Moles/volume] in Serum or Plasma
203
592
3.88
60.66
3.3
1.9
nmol/l
11.8
13.1
1.19
179
518
(3020630) Protein [Mass/volume] in Serum or Plasma
239
780
3.53
60.38
2.5
3.0
g/l
64.6
66.8
4.15
224
714
(3002032) Base excess in Venous blood by calculation
267
940
3.32
59.75
8.3
4.2
mmol/l
2.2
1.8
0.62
231
763
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
83
110
7.99
59.54
1.8
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
540
2788
2.60
59.07
4.6
3.0
ng/l
1273.8
1145.9
0.25
482
2360
(3025941) Bacteria identified in Stool by Culture
202
600
3.80
58.70
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
546
2847
2.58
58.34
6.5
3.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
577
3089
2.56
58.31
4.9
3.1
e6/l
20.9
85.0
2.26
505
2372
(3011412) CD3 cells [#/volume] in Blood
76
94
8.52
57.70
1.9
2.4
e9/l
1.3
1.3
0.11
54
50
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
66
69
10.02
56.97
1.9
2.0
%
14.4
12.0
0.48
30
39
(3028626) Oxygen [Partial pressure] in Capillary blood
131
287
4.96
56.70
5.7
3.8
kpa
8.5
8.6
0.23
131
266
(3029937) Albumin [Presence] in Urine by Test strip
530
2773
2.54
55.64
7.0
3.9
estimate
0.0
0.0
1.28
300
928
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
94
155
6.46
55.22
1.9
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
219
715
3.48
55.01
3.9
3.5
ng/l
72.3
78.4
0.57
183
627
(3030467) Casts [#/volume] in Urine by Automated count
535
2831
2.51
54.59
4.5
3.0
e6/l
0.4
0.5
0.41
474
2131
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
179
5.97
54.08
2.0
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
162
439
4.07
53.40
1.7
1.4
u/ml
3.2
15.5
—
6
8
(3014576) Chloride [Moles/volume] in Serum or Plasma
302
1214
2.94
53.23
11.2
7.2
mmol/l
102.8
104.3
4.49
294
1182
(3004588) Protein electrophoresis panel - Serum or Plasma
206
662
3.51
52.93
2.2
2.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
239
847
3.23
52.43
11.2
7.2
mmol/l
8.7
9.0
0.35
234
814
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
76
106
7.55
52.11
1.7
1.2
nmol/l
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
82
126
6.88
51.50
1.7
1.2
nmol/l
0.2
0.4
—
8
9
(3027945) Reticulocytes/100 erythrocytes in Blood
277
1087
2.97
50.80
3.1
2.8
%
1.9
1.8
1.18
239
978
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
54
50
11.22
50.65
1.9
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
78
116
7.09
50.48
1.7
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
54
51
11.00
49.98
1.9
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
468
2407
2.47
49.87
2.8
1.8
mg/l
1.1
1.2
0.32
357
1844
(3035350) Ketones [Presence] in Urine by Test strip
798
5184
2.40
49.84
6.6
3.5
estimate
0.0
0.0
0.00
305
947
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
438
2190
2.51
49.57
2.1
1.7
pmol/l
17742393.4
45539565.3
0.67
372
1827
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
254
962
3.04
49.53
3.0
2.2
g/l
0.2
0.2
0.13
231
914
(3013707) Erythrocyte sedimentation rate by Westergren method
1062
7888
2.89
49.42
9.4
4.0
mm/h
14.3
11.9
6.11
1010
7311
(3023520) Reticulocytes [#/volume] in Blood
223
784
3.23
49.41
2.7
2.9
e9/l
75.0
71.2
0.70
174
598
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1105
8404
3.09
48.72
8.4
4.0
pmol/l
15.3
14.7
10.84
1057
7671
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
61
9.73
48.31
1.8
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
474
2483
2.43
48.19
1.6
1.3
u/ml
1.4
1.7
0.33
176
642
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
661
4008
2.32
47.80
7.1
3.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
94
179
5.58
47.55
1.5
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
73
108
7.10
47.45
1.8
2.3
pg
31.3
32.5
1.09
73
108
(3042631) Mycobacterium sp identified in Specimen
81
134
6.38
47.36
3.9
2.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
508
2767
2.37
47.04
4.6
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
798
5268
2.33
46.78
6.7
3.6
estimate
0.0
0.0
0.80
306
922
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
85
150
5.99
46.57
1.8
1.4
nmol/l
0.3
0.4
0.32
55
124
(3021601) Nitrite [Presence] in Urine by Test strip
791
5219
2.32
46.18
8.6
4.9
estimate
0.0
0.0
0.50
313
961
(3018095) Leukocytes [#/volume] in Urine
615
3662
2.29
45.88
5.7
3.6
e6/l
46.1
86.3
1.42
524
2563
(3023323) Follitropin [Units/volume] in Serum or Plasma
166
508
3.60
45.70
1.7
1.3
iu/l
26.1
27.9
0.27
146
426
(3024354) Oxygen [Partial pressure] in Venous blood
219
802
3.08
45.03
8.3
3.7
kpa
4.6
4.6
0.12
211
775
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
96
197
5.18
44.67
5.6
6.0
iu/ml
247.7
309.5
—
10
27
(3019309) Folate [Moles/volume] in Red Blood Cells
374
1811
2.49
44.65
2.1
1.7
nmol/l
1395.5
1173.9
3.58
287
1360
(3026008) Bacteria identified in Urine by Culture
554
3189
2.28
44.47
4.9
3.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
132
351
4.07
44.44
2.3
1.6
titre
128.6
142.7
0.09
14
15
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
669
4163
2.25
44.39
2.4
1.9
pmol/l
92.8
96.3
1.27
421
2124
(3016038) Potassium [Moles/volume] in Urine
59
75
8.19
43.71
1.4
1.3
mmol/l
31.8
33.1
0.13
53
70
(3021960) Folate [Moles/volume] in Serum or Plasma
448
2386
2.34
42.92
1.8
1.5
nmol/l
20.9
21.3
0.20
407
2039
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
149
446
3.64
42.31
2.5
2.0
u/l
37.6
39.6
0.48
136
403
(3018677) aPTT in Platelet poor plasma by Coagulation assay
334
1575
2.51
41.87
2.9
2.2
s
29.8
29.6
0.19
320
1528
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
177
598
3.27
41.54
2.0
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
77
138
5.87
41.48
1.7
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
210
789
2.98
41.06
1.3
1.2
iu/ml
168.2
158.3
0.11
81
304
(3031040) Bacteria [#/volume] in Urine by Automated count
952
6971
2.36
40.95
8.2
4.4
e6/l
793.3
2679.4
1.06
17
105
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
585
3530
2.19
40.91
5.8
3.2
u/l
33.8
32.4
0.27
551
3362
(3007930) Methemoglobin/Hemoglobin.total in Blood
135
387
3.78
40.81
8.2
6.6
%
0.9
0.9
0.46
130
366
(3014111) Lactate [Moles/volume] in Serum or Plasma
224
878
2.87
40.51
10.4
7.7
mmol/l
1.3
1.4
0.10
212
844
(3004809) Band form neutrophils/100 leukocytes in Blood
80
152
5.54
40.50
3.0
3.3
%
0.9
1.3
1.01
71
122
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
135
390
3.75
40.35
8.3
6.5
%
1.5
1.6
0.59
130
369
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
63
96
6.85
39.80
1.7
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
217
850
2.86
39.22
12.3
8.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
117
313
4.01
38.97
3.3
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
279
1254
2.56
38.38
2.1
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
92
208
4.68
38.12
3.3
4.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
39
34
11.79
37.95
6.3
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
974
7310
2.32
37.80
8.0
4.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
83
174
5.03
37.62
1.3
1.1
iu/ml
29.5
122.5
0.89
35
41
(3034860) Kappa light chains.free [Mass/volume] in Serum
109
284
4.10
37.62
3.1
4.1
mg/l
44.3
71.1
0.55
66
234
(40768797) Stomach Pathology biopsy report
304
1438
2.45
37.39
1.4
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
106
276
4.09
36.60
3.1
4.1
ratio
1.2
1.8
0.47
11
28
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
88
199
4.67
36.44
2.1
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
289
1351
2.46
36.37
3.9
2.4
ug/g
217.6
117.5
2.23
251
1073
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
107
284
4.02
35.98
3.1
4.2
mg/l
24.4
46.7
1.25
63
235
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
105
278
4.02
35.43
2.2
2.0
mg/l
8.6
11.7
4.08
99
259
(3026389) Candida sp identified in Specimen by Organism specific culture
68
128
5.55
34.74
1.8
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
116
340
3.65
33.82
1.6
1.6
g/l
0.2
0.2
0.49
105
323
(3023183) Ammonium ion [Moles/volume] in Plasma
89
216
4.35
33.70
2.3
3.1
umol/l
29.8
33.8
0.86
73
188
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
118
353
3.58
33.36
1.6
1.6
g/l
1.3
1.2
1.66
108
335
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
31
23
13.78
33.17
1.9
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
148
523
3.06
31.92
8.1
4.6
mmol/l
24.5
24.0
0.72
135
477
(21494814) CD8 cells/100 lymphocytes in Specimen
33
29
11.65
31.89
1.8
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
109
320
3.63
31.67
1.6
1.5
ug/g
247.6
292.1
1.34
70
189
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
48
75
6.61
29.58
1.8
2.5
e6/l
561.2
473.8
0.47
37
64
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
108
332
3.46
29.23
2.6
2.2
ug/l
402.5
476.5
0.15
102
309
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
44
65
6.97
28.56
1.4
1.4
u/l
8.3
6.3
0.24
39
53
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
46
73
6.50
27.93
1.8
2.5
e9/l
0.3
0.2
0.56
37
63
(3020891) Body temperature
116
385
3.21
27.74
9.1
5.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
138
509
2.91
27.47
13.5
11.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
242
1177
2.30
27.16
4.2
2.7
umol/l
5.7
7.8
1.87
196
1019
(3047181) Lactate [Moles/volume] in Blood
99
306
3.42
26.54
9.0
7.9
mmol/l
1.3
1.3
0.05
86
271
(3037756) Immunofixation for Serum or Plasma
80
216
3.88
26.20
1.5
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
58
123
4.89
25.90
9.0
6.0
mg/l
11.8
11.2
0.36
52
114
(3013512) EKG study
464
2921
1.91
25.80
5.9
3.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
122
438
2.97
25.46
9.4
3.9
%
47.2
50.6
0.76
122
431
(43055514) Macroprolactin [Presence] in Serum or Plasma
23
16
14.62
25.40
1.4
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
428
2636
1.93
25.34
3.7
2.6
umol/l
4262.3
5828.6
0.36
370
2294
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1159
9929
2.53
24.95
9.3
4.7
mu/l
2.1
2.0
0.07
1103
9123
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
28
29
9.85
24.17
2.2
4.6
au/ml
170.1
31.9
—
9
7
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
50
99
5.21
24.15
1.5
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
53
114
4.80
23.28
2.1
1.5
%
52.2
59.3
0.53
35
76
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
114
414
2.92
23.27
1.8
2.0
g/l
1.6
1.5
0.60
99
364
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
41
73
5.77
22.20
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
321
1871
1.95
21.90
4.6
2.9
mmol/l
2.4
2.4
0.28
290
1650
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
323
1891
1.94
21.72
1.5
1.3
iu/ml
17.7
31.8
3.72
107
599
(3004451) EKG impression Narrative
32
46
7.11
21.27
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
226
1177
2.11
21.01
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
99
352
2.96
20.97
1.9
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
126
509
2.63
20.97
7.4
4.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
19
14
13.76
20.25
1.8
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
73
221
3.44
20.19
2.3
1.5
nmol/l
55.6
41.5
1.51
73
211
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
96
343
2.94
20.16
1.9
1.6
iu/ml
0.2
0.1
0.29
22
63
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
88
300
3.07
20.06
3.8
3.4
u/ml
0.3
0.4
1.83
57
169
(3019550) Sodium [Moles/volume] in Serum or Plasma
1219
10935
2.82
19.57
45.4
15.0
mmol/l
139.0
139.6
11.87
1210
10645
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
40
80
5.13
19.11
2.4
1.3
%
31.1
31.2
0.01
25
50
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
24
28
8.71
18.93
1.3
1.1
pmol/l
397.1
320.9
0.21
12
18
(3044889) 12 lead EKG panel
905
7352
1.76
18.87
5.8
3.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
81
273
3.10
18.83
1.3
1.2
titre
248.3
93.0
—
6
20
(3023103) Potassium [Moles/volume] in Serum or Plasma
1219
10968
2.77
18.83
45.5
15.1
mmol/l
3.9
4.0
10.51
1210
10657
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
666
4984
1.69
18.78
6.5
4.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
40
82
5.00
18.59
1.2
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
22
24
9.31
18.24
3.3
4.0
%
43.9
53.4
0.79
22
24
(3034891) Synovial lining cells/100 cells in Synovial fluid
28
42
6.79
17.90
2.0
1.3
%
1.8
2.0
—
6
11
(4035726)
178
899
2.14
17.76
1.6
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
63
190
3.43
17.54
1.4
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
85
307
2.89
17.50
7.6
4.2
mmol/l
3.8
3.9
0.38
79
280
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
25
34
7.48
17.42
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
72
239
3.13
17.18
1.7
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
458
3158
1.69
17.16
3.9
3.2
mmol/l
6.9
7.4
1.77
401
2665
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
132
598
2.34
17.13
2.4
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
115
490
2.48
17.09
11.4
10.9
mmol/l
23.9
24.3
0.49
109
463
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
73
246
3.08
16.98
1.4
1.4
mmol/l
3.6
3.7
0.44
68
228
(3044290) Cell count panel - Cerebral spinal fluid
68
220
3.21
16.93
1.4
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
84
310
2.83
16.62
5.6
2.9
g/l
3.2
3.5
1.38
74
298
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
71
239
3.08
16.55
1.6
1.7
e6/l
112.7
281.4
0.78
56
190
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
71
239
3.08
16.55
1.5
1.6
e6/l
28.6
34.0
0.08
50
183
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1107
9688
1.96
16.54
8.4
5.5
mmol/mol
41.6
39.6
8.13
1059
9008
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
160
797
2.15
16.50
5.6
2.9
ng/l
96.9
182.2
5.99
148
723
(3017143) Hepatitis C virus Ab [Presence] in Serum
216
1203
1.95
16.41
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
295
1818
1.81
16.33
1.4
1.3
u/ml
8.5
11.1
0.34
132
699
(3017704) Immunofixation for Urine
31
57
5.55
16.24
1.9
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1053
9093
1.83
16.09
42.8
16.2
%
14.2
13.6
19.05
1044
8899
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1193
10757
2.31
16.04
41.7
13.2
mg/l
21.0
22.7
1.48
1102
8411
(3012516) Albumin [Mass/volume] in Urine
421
2880
1.68
16.02
4.0
3.2
mg/l
822.6
414.4
0.61
268
1797
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
44
111
4.07
15.84
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
33
66
5.10
15.78
2.7
2.5
%
41.6
43.6
0.14
19
16
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
51
146
3.59
15.38
1.8
1.3
u/l
28.5
28.8
0.02
43
118
(3039162) Centromere protein B Ab [Units/volume] in Serum
47
128
3.77
15.24
1.6
1.3
u/ml
48.8
54.0
—
9
7
(44806118)
47
129
3.74
15.07
2.1
1.5
—
—
—
0
0
(44790049)
47
129
3.74
15.07
2.1
1.5
—
—
—
0
0
(44790048)
47
129
3.74
15.07
2.1
1.5
—
—
—
0
0
(44790047)
47
129
3.74
15.07
2.1
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
37
85
4.45
15.03
1.4
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
31
7.20
14.85
1.5
2.3
e6/l
341.4
308.9
—
7
18
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
65
222
3.03
14.79
1.5
1.2
u/ml
17.6
45.4
—
7
22
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
37
87
4.35
14.61
1.7
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
26
45
5.88
14.49
2.8
3.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
102
446
2.40
14.32
1.5
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
859
7140
1.60
13.83
6.1
3.0
u/l
66.7
45.1
3.59
804
6687
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
62
4.93
13.83
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
33
74
4.55
13.82
1.7
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
301
1953
1.70
13.63
1.9
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
33
75
4.49
13.60
1.7
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
71
4.60
13.58
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
44
125
3.61
13.44
1.8
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
29
61
4.84
13.11
1.3
1.3
nmol/l
141.6
146.9
0.20
29
61
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
76
302
2.61
13.06
1.5
1.2
u/ml
6.8
19.4
—
5
15
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
59
205
2.97
13.05
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
59
205
2.97
13.05
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
49
154
3.27
12.83
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
73
288
2.63
12.73
2.2
1.8
iu/l
105.8
5.4
0.49
31
93
(3016018) Differential panel - Cerebral spinal fluid
40
111
3.69
12.65
1.5
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
50
162
3.17
12.46
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
25
49
5.18
12.24
2.8
2.3
mmol/l
9.0
9.2
0.15
19
41
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
196
2.94
12.24
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
421
3041
1.57
12.16
4.9
3.9
mg/mmol
12.1
8.7
0.69
268
1892
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
252
1608
1.70
11.99
1.8
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
29
6.63
11.93
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
281
2.58
11.80
1.5
1.2
u/ml
3.3
2.7
—
6
34
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
10
12.10
11.75
2.8
1.5
umol/l
44.3
37.8
—
12
10
(3021879) Hepatitis B virus core Ab [Presence] in Serum
142
766
1.96
11.69
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
59
4.65
11.68
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
59
4.65
11.68
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
1009
0.30
11.46
1.3
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
70
286
2.53
11.39
1.5
1.2
u/ml
5.3
8.0
—
10
54
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
51
179
2.92
11.11
1.4
1.5
u/ml
101.9
107.5
0.16
16
37
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
28
6.50
11.11
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
27
62
4.43
11.01
1.3
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
25
54
4.70
10.97
1.2
1.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
31
80
3.95
10.87
1.2
1.1
mg/l
422.0
239.1
0.65
22
65
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
57
217
2.70
10.69
1.5
1.2
u/ml
2.9
5.6
—
7
20
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
26
6.61
10.65
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1105
9990
1.70
10.62
33.0
12.0
ml/min/173m2
80.2
82.3
2.28
1025
8177
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
248
1623
1.65
10.61
4.1
2.8
e6/l
4.1
2.8
0.78
159
879
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
35
101
3.53
10.49
3.9
5.0
u/ml
159.9
83.8
0.37
13
32
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
111
3.40
10.46
1.9
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
56
214
2.69
10.43
9.6
4.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
444
3343
1.50
10.21
3.6
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
24
6.74
10.19
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
31
84
3.76
10.18
1.3
1.1
mg/l
63.4
36.6
0.65
19
65
(3052592) Norovirus Ag [Presence] in Stool
14
18
7.85
10.15
1.1
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
196
1219
1.72
10.13
25.8
23.7
inr
1.3
1.3
0.02
20
164
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
26
62
4.26
10.12
1.3
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
369
2.24
9.96
2.8
2.4
g/l
7.5
7.4
0.06
52
288
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
369
2.24
9.96
2.8
2.4
g/l
3.6
3.8
0.44
51
276
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
369
2.24
9.96
2.8
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
95
3.54
9.93
5.6
3.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
33
95
3.54
9.93
2.0
2.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
364
2643
1.52
9.90
6.7
3.8
%
91.2
91.9
0.19
350
2566
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
13
9.31
9.88
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
281
1928
1.58
9.85
6.9
3.8
ng/l
154.0
318.9
1.33
201
1453
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
71
316
2.32
9.61
2.2
2.7
g/l
0.4
1.0
0.79
58
283
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
44
4.83
9.55
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
11
11
10.08
9.55
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
370
2722
1.50
9.38
10.1
6.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
125
3.10
9.29
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
77
360
2.21
9.29
2.1
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
347
2.23
9.28
2.8
2.5
g/l
3.0
3.1
0.32
54
282
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
381
2825
1.49
9.28
1.8
1.6
mmol/l
1.6
1.4
5.10
313
2388
(36660697) Celiac disease serology panel - Serum
148
872
1.79
9.22
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
694
0.25
9.20
1.2
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
337
2.24
9.08
1.5
1.3
—
—
—
0
0
(4027681)
27
72
3.81
9.08
1.7
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
33
101
3.33
9.07
1.2
1.2
u/l
70.3
56.9
0.46
26
72
(21494755) Public health laboratory ask at order entry panel
45
1075
0.40
8.97
1.3
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
5
24.19
8.91
1.0
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
162
2.78
8.83
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
36
119
3.08
8.74
3.7
4.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
410
2.09
8.73
3.3
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
43
158
2.78
8.67
1.5
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
164
1014
1.71
8.62
3.3
4.2
ug/l
24.5
25.2
0.01
138
824
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
378
2.13
8.62
2.3
2.1
u/l
1437.6
4015.3
0.86
31
157
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
62
274
2.33
8.56
2.1
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
14
22
6.42
8.54
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
29
5.57
8.51
1.1
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
22
53
4.21
8.47
3.0
3.5
ph
7.4
7.4
0.16
11
13
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
49
4.34
8.42
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
823
7121
1.42
8.36
3.7
3.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
197
2.55
8.30
1.5
1.3
u/ml
331.3
258.3
0.70
41
113
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
56
241
2.38
8.21
1.5
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
34
5.05
8.15
4.5
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
50
207
2.47
7.98
1.5
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
829
9281
0.71
7.97
44.0
17.2
g/l
331.2
332.2
2.46
822
9217
(3037121) Protein [Mass/volume] in Urine
72
349
2.13
7.97
4.3
3.5
g/l
0.4
0.3
0.45
41
147
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
16
31
5.21
7.94
2.9
1.9
mg/l
9.1
10.3
—
9
26
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
55
239
2.36
7.90
2.1
1.8
nmol/l
1.2
0.8
1.36
44
204
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
28
5.41
7.74
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
44
4.37
7.69
1.0
1.1
miu/ml
1641.4
1584.7
0.09
19
44
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
247
1738
1.52
7.56
3.7
2.7
e6/l
2.2
1.1
0.38
158
991
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
153
964
1.67
7.48
3.7
2.3
u/l
37.4
93.0
0.57
134
816
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
30
98
3.11
7.46
1.5
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
30
98
3.11
7.46
1.5
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
30
98
3.11
7.46
1.5
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
65
311
2.15
7.45
4.2
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
529
4319
1.38
7.16
2.5
2.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
10
5
20.14
7.14
5.7
6.8
mg/l
31.9
21.2
—
10
5
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
346
2.05
7.01
2.8
2.5
g/l
8.5
10.4
3.70
57
301
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
113
667
1.76
7.00
1.4
1.3
au/ml
52.7
44.4
—
8
43
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
20
52
3.89
6.99
1.8
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1195
11272
1.74
6.95
38.3
12.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
129
792
1.70
6.95
4.2
2.5
ml/min/173m2
58.5
68.7
2.18
63
317
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
11
8
13.85
6.89
2.4
3.0
pmol/l
41.5
96.0
—
6
8
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
62
3.59
6.88
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
82
3.21
6.86
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
82
3.21
6.86
1.8
2.3
e6/l
758.7
751.4
0.02
12
33
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
44
185
2.43
6.83
2.0
3.8
u/ml
688.9
1983.8
0.41
37
173
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
73
378
1.99
6.80
3.3
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1205
11406
1.77
6.74
23.2
10.0
u/l
27.0
25.7
1.01
1191
11026
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
63
3.53
6.73
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
14
28
5.04
6.71
1.5
1.3
%
55.2
61.6
—
9
21
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
122
2.75
6.63
1.1
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
21
5.76
6.59
2.3
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
69
3.38
6.57
2.0
1.4
u/ml
26.4
22.7
—
7
14
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
50
3.84
6.54
1.7
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
50
3.84
6.54
1.7
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
50
3.84
6.54
1.7
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
50
3.84
6.54
1.7
2.1
—
—
—
0
0
(3036489) Thrombin time
75
399
1.93
6.48
3.7
2.3
s
20.6
21.3
1.01
67
357
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
17
42
4.09
6.36
1.0
1.0
ng/l
182.9
61.0
—
7
10
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
34
131
2.64
6.33
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
34
4.45
6.24
1.1
1.5
%
114.6
83.0
—
9
16
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
52
3.69
6.21
2.6
3.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
128
810
1.64
6.15
3.2
2.4
ug/l
5.3
7.1
0.69
113
720
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
67
3.32
6.15
1.3
1.5
u/l
7.8
6.7
0.10
12
32
(3028433) Virus identified in Specimen by Culture
16
39
4.14
6.09
1.4
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
39
4.14
6.09
1.9
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
39
4.14
6.09
1.9
2.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
8
12.58
6.08
1.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
33
128
2.62
6.07
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
73
3.19
6.03
1.8
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
15
35
4.32
6.03
1.1
1.1
%
104.0
81.4
—
9
16
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
58
3.49
6.02
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
129
2.60
5.99
5.0
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
26
90
2.93
5.91
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
40
4.04
5.90
1.9
2.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
15
36
4.20
5.83
1.4
2.5
—
73852.2
—
0
6
(3021788) Differential panel - Synovial fluid
42
187
2.29
5.78
1.9
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
28
4.68
5.74
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
28
4.68
5.74
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
17
46
3.73
5.65
1.7
1.9
ug/l
20.3
202.5
0.48
17
38
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
273
2065
1.41
5.62
1.8
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
292
2.00
5.52
1.3
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
8
5
16.09
5.41
2.1
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
73
3.05
5.39
1.5
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
43
3.75
5.37
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
19
58
3.31
5.31
2.7
3.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
57
297
1.96
5.28
1.5
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
144
2.40
5.26
2.0
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
44
3.67
5.21
1.3
1.1
—
—
—
0
0
(44813793)
23
80
2.91
5.21
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1099
10303
1.43
5.12
5.9
4.4
mmol/l
5.8
5.9
0.57
1040
9403
(3044941) Cell count panel - Synovial fluid
37
165
2.28
5.11
1.8
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
23
81
2.87
5.10
1.1
1.1
nmol/l
0.7
1.6
—
5
14
(3020876) Protein [Mass/time] in 24 hour Urine
22
76
2.93
5.04
1.9
1.9
—
1.4
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
87
525
1.70
5.04
2.8
2.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
141
2.38
5.02
2.0
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
23
4.81
5.02
2.6
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
820
1.57
4.99
6.0
3.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
36
3.92
4.99
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
28
111
2.56
4.98
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
24
4.61
4.78
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
24
4.61
4.78
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
24
4.61
4.78
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
24
4.61
4.78
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
293
2299
1.35
4.75
6.9
3.8
kg/l
1.0
1.0
0.83
51
321
(3017354) Segmented neutrophils/100 leukocytes in Blood
25
97
2.61
4.65
3.0
3.4
%
60.6
53.8
0.79
19
69
(3023410) Appearance of Cerebral spinal fluid
28
115
2.47
4.65
1.7
2.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
47
240
1.99
4.64
1.2
1.1
u/ml
0.5
2.7
2.12
22
111
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
53
3.24
4.62
1.5
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
53
3.24
4.62
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
32
141
2.30
4.57
2.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
32
141
2.30
4.57
2.0
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
27
110
2.49
4.56
1.7
1.4
g/l
25.1
33.4
2.34
27
96
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
11
8.23
4.56
1.6
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
104
2.53
4.56
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
32
142
2.29
4.50
2.0
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
54
3.18
4.49
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
32
144
2.25
4.36
2.0
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
89
2.61
4.32
3.3
2.4
u/field
1.3
2.1
—
10
37
(1761482) Bacteria [#/volume] in Urine by Culture
50
269
1.89
4.27
8.5
4.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
53
293
1.84
4.17
1.9
2.4
g/l
37.4
37.8
0.16
48
262
(21494890) Protein electrophoresis panel - 24 hour Urine
24
97
2.50
4.14
3.0
2.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
57
3.01
4.13
1.1
1.2
ratio
1.2
1.1
—
8
24
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
23
4.37
4.09
2.0
3.9
—
—
—
0
0
(3035880) pH of Pleural fluid
16
52
3.10
4.09
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
32
3.78
4.09
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
63
2.88
4.07
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
138
979
1.46
4.01
6.7
3.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
14
6.46
3.98
1.1
2.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
48
3.15
3.93
1.1
3.9
umol/l
59.8
122.7
—
5
30
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
33
3.66
3.92
1.5
2.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
24
100
2.43
3.90
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
94
2.47
3.89
1.6
1.6
—
—
—
0
0
(4306422)
32
152
2.13
3.86
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
180
2.03
3.81
1.6
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
114
2.31
3.79
2.2
2.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
44
3.21
3.78
2.2
1.6
iu/ml
—
1224630.0
—
0
5
(3042517) Benzodiazepines panel - Urine
7
8
8.79
3.77
3.6
1.0
—
—
—
0
0
(4010399)
111
764
1.50
3.76
1.7
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
5
12.05
3.76
2.3
5.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
54
311
1.77
3.75
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
155
2.09
3.69
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
16
5.66
3.66
2.2
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
130
2.18
3.59
1.5
2.0
umol/l
7.7
5.5
0.59
23
90
(3023430) Cat dander IgE Ab [Units/volume] in Serum
31
151
2.08
3.53
1.1
1.1
u/ml
7.0
3.6
0.30
14
60
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
46
3.07
3.53
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
31
3.57
3.48
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
55
329
1.70
3.37
1.5
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
18
5.03
3.37
1.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
60
368
1.66
3.36
2.9
3.2
u/ml
101.2
861.1
1.09
52
316
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
14
5.74
3.34
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
14
5.74
3.34
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
32
3.46
3.33
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
44
248
1.80
3.31
2.2
1.6
e6/l
4474.2
14743.1
2.35
36
183
(3017732) Neutrophils [#/volume] in Blood
107
754
1.46
3.25
4.0
2.8
e9/l
4.8
4.1
1.95
81
603
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
19
4.76
3.24
1.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
28
136
2.08
3.23
1.1
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
12
38
3.18
3.21
1.3
1.1
u/ml
0.4
21.2
—
6
23
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
306
2548
1.26
3.09
3.4
2.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
34
3.25
3.06
1.9
1.3
ug/l
10.0
9.1
0.32
11
34
(3022229) Phosphate [Moles/volume] in Urine
6
8
7.53
3.05
1.2
7.5
mmol/l
14.1
12.6
—
6
8
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
203
1.85
3.05
1.2
1.1
u/ml
0.5
2.7
1.79
13
52
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
45
2.91
3.03
1.1
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
19
81
2.37
2.99
1.2
1.2
titre
140.0
103.1
—
5
13
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
5
10.03
2.98
2.4
1.4
umol/l
1.5
1.3
—
5
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
40
3.02
2.97
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
162
1.94
2.96
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
171
1.89
2.87
1.1
1.2
u/ml
4.3
3.7
—
7
52
(4034850)
53
329
1.64
2.87
23.3
10.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
53
329
1.64
2.87
1.6
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
83
2.31
2.85
2.4
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
47
2.78
2.82
2.2
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
173
1356
1.32
2.79
1.4
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
325
0.42
2.74
1.4
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
91
2.22
2.74
1.2
1.4
mmol/l
10.4
11.7
0.37
12
21
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
34
189
1.82
2.72
1.8
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
132
1.99
2.71
1.8
2.2
u/ml
159.7
37.9
0.35
26
125
(3050794) Legionella sp Ab [Presence] in Serum
6
10
6.02
2.70
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
197
1.80
2.69
2.1
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
53
335
1.61
2.69
1.6
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
294
0.40
2.68
1.3
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
19
4.23
2.68
1.4
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
24
3.77
2.67
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
24
3.77
2.67
1.8
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
236
1.72
2.64
2.3
2.3
ug/min
66.5
115.3
0.63
27
148
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
15
4.69
2.60
1.1
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
5
7
7.17
2.55
1.8
1.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
14
56
2.52
2.53
2.4
2.7
—
22.6
—
0
8
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
88
2.18
2.51
1.5
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
16
4.39
2.47
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
203
1.74
2.46
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
30
166
1.83
2.46
1.1
1.1
u/ml
1.8
2.8
0.50
18
67
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
45
2.68
2.45
1.1
1.1
iu/ml
139.3
192.3
0.34
12
45
(4198724)
12
45
2.68
2.45
1.6
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
34
2.96
2.41
1.2
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
68
468
1.48
2.39
1.9
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
27
3.35
2.39
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
58
2.43
2.37
7.1
7.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
98
2.06
2.32
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
35
2.87
2.30
2.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
35
2.87
2.30
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
35
2.87
2.30
2.1
2.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
35
2.87
2.30
1.7
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
35
2.87
2.30
2.1
2.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
35
2.87
2.30
1.7
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
494
0.58
2.29
1.5
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
13
4.63
2.27
1.2
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
23
3.49
2.27
3.9
3.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
79
2.17
2.25
1.7
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
66
2.29
2.25
1.3
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
271
0.44
2.24
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
271
0.44
2.24
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
73
517
1.44
2.24
6.8
3.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
217
1.68
2.24
1.1
1.1
u/ml
0.3
7.0
5.95
16
127
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
270
0.44
2.22
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
270
0.44
2.22
1.3
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
24
3.35
2.18
2.0
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
87
2.08
2.17
1.8
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
14
4.30
2.15
1.5
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
42
267
1.59
2.14
1.4
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
316
1.54
2.11
1.4
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.09
2.07
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
82
2.09
2.07
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.09
2.07
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
41
625
0.64
2.07
1.7
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
334
1.52
2.06
1.3
1.3
miu/ml
234.1
238.9
0.03
18
157
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
58
401
1.47
2.03
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
83
2.06
2.01
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
83
2.06
2.01
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
83
2.06
2.01
1.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1229
12030
1.39
2.00
54.1
19.6
e9/l
7.8
6.7
21.29
1216
11717
(1761868) Lipid panel - Serum or Plasma
437
3916
1.17
2.00
3.6
2.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
171
1.71
1.97
1.1
1.2
u/ml
4.0
3.6
0.08
11
71
(3007461) Platelets [#/volume] in Blood
1228
12023
1.38
1.95
54.1
19.5
e9/l
271.6
254.7
11.99
1218
11739
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
16
3.76
1.93
1.5
3.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
21
113
1.87
1.92
1.2
1.4
—
34.0
—
0
5
(3010144) Erythrocytes [#/volume] in Synovial fluid
19
99
1.93
1.91
2.3
1.3
e6/l
2729.0
201435.4
1.12
12
63
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
204
1.63
1.90
1.6
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1228
12029
1.37
1.89
54.0
19.5
e12/l
4.4
4.5
9.80
1218
11717
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
52
2.32
1.88
1.1
1.3
pmol/l
24.9
57.4
—
7
13
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
17
3.54
1.84
1.3
1.0
mg/g
22.6
6.4
—
6
17
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
208
1.60
1.78
1.1
1.1
u/ml
0.1
1.2
1.48
11
105
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
18
3.34
1.74
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
13
3.86
1.71
1.2
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
48
2.30
1.70
3.1
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
47
0.00
1.70
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
75
2.01
1.70
2.7
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
277
2421
1.18
1.69
5.8
3.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
405
0.61
1.69
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
119
1.78
1.66
1.2
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
31
2.59
1.66
1.5
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
224
0.49
1.62
1.4
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
14
3.58
1.61
4.2
3.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
84
1.92
1.60
2.6
6.6
%
10.5
11.1
0.19
16
84
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
20
3.01
1.58
1.3
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
20
3.01
1.58
2.0
1.9
mmol/l
1.1
1.2
—
6
20
(3023511) Choriogonadotropin [Units/volume] in Urine
34
223
1.54
1.58
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
156
0.45
1.55
1.7
1.6
—
—
—
0
0
(4015189)
8
33
2.43
1.54
2.5
2.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
1.0
1.4
mmol/l
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
218
0.50
1.51
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
217
0.50
1.49
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
52
2.12
1.44
1.2
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
29
2.42
1.39
1.1
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
121
1457
0.81
1.38
3.2
2.9
ug/l
0.9
0.8
0.31
88
925
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
152
1284
1.21
1.37
2.1
1.8
%
1.6
1.5
0.70
114
1142
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1042
10096
1.16
1.37
4.8
3.8
mmol/l
1.5
1.3
8.47
959
9287
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
15
82
1.84
1.36
1.3
1.5
promille
1.3
1.4
—
9
68
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
277
2466
1.16
1.35
5.2
4.8
ug/l
7.4
3.1
0.47
248
2208
(3051593) INR in Capillary blood by Coagulation assay
10
47
2.14
1.34
20.8
13.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
68
1.92
1.33
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
105
1.72
1.33
2.3
2.2
—
—
—
0
0
(3000492) Spirometry study
126
1050
1.22
1.31
1.7
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
24
2.51
1.30
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
34
2.36
1.29
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
114
1.68
1.28
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
44
2.05
1.27
2.4
2.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
25
2.41
1.24
11.2
6.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
19
2.64
1.21
2.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
49
366
1.35
1.21
2.1
2.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
21
132
1.60
1.20
1.5
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
26
2.31
1.18
3.5
1.2
%
59.3
56.8
—
6
21
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
38
273
1.40
1.18
2.1
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
20
2.51
1.15
1.4
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
114
0.44
1.12
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
184
1.48
1.11
2.8
3.2
nmol/l
0.9
0.8
0.22
19
144
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
169
1.49
1.07
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
105
1.63
1.06
1.4
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
22
2.28
1.03
1.4
2.8
u/l
88.6
3709.3
—
5
22
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
236
0.63
0.98
1.6
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
69
1.75
0.96
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1072
10476
1.13
0.96
5.3
4.2
mmol/l
1.5
1.5
0.82
989
9684
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1078
10539
1.13
0.95
5.4
4.3
mmol/l
4.6
4.7
1.89
998
9794
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
50
391
1.29
0.95
1.5
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
27
2.23
0.93
11.2
6.6
—
—
—
0
0
(4281824)
7
129
0.54
0.88
1.3
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
36
274
1.32
0.84
1.4
1.4
pmol/l
75.4
226.2
1.70
36
268
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
172
1.40
0.81
1.3
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
26
190
1.38
0.79
1.1
1.1
—
12.6
—
0
13
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
24
0.00
0.79
0.0
1.0
—
38.4
—
0
24
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
70
586
1.21
0.77
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
53
1.70
0.75
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
141
1.42
0.74
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
68
1.62
0.71
1.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
229
1.32
0.71
5.8
3.5
mg/l
24.5
24.7
0.01
24
150
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
93
1.51
0.69
1.1
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
13
85
1.53
0.69
2.0
1.7
mmol/l
7.4
6.6
—
7
57
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
42
1.67
0.68
3.1
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
59
1.53
0.68
2.7
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
41
329
1.25
0.68
2.4
2.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
70
1.58
0.65
4.6
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1088
10703
1.10
0.63
5.8
4.7
mmol/l
2.6
2.8
6.17
999
9895
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
21
0.00
0.60
0.0
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
21
0.00
0.60
0.0
3.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
53
1.51
0.58
1.8
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
53
1.51
0.58
1.8
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
596
1.17
0.57
1.5
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
35
1.72
0.57
4.8
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
86
0.58
0.56
1.4
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
47
394
1.20
0.55
2.6
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
108
1.39
0.53
5.1
3.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
39
1.54
0.53
1.2
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
166
0.72
0.48
1.5
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
68
1.47
0.47
1.3
1.1
u/ml
0.6
2.5
—
5
23
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
181
1943
0.92
0.46
1.6
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
199
0.75
0.46
3.2
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
35
295
1.19
0.42
3.9
2.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
311
2967
1.06
0.41
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
77
691
1.12
0.41
6.6
2.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
18
141
1.28
0.40
1.1
1.0
u/ml
0.1
0.4
—
7
43
(3019832) Treponema pallidum Ab [Presence] in Serum
112
1028
1.10
0.40
1.8
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
131
1215
1.09
0.38
1.7
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
67
1.35
0.38
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
45
392
1.15
0.38
1.5
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
24
290
0.82
0.37
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
76
687
1.11
0.37
1.9
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
117
1262
0.92
0.36
5.4
4.3
%
31.9
32.4
0.18
94
863
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
73
1.37
0.34
4.0
1.4
g/l
1.0
1.0
—
10
73
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
6
45
1.33
0.33
3.7
3.0
umol/l
27.3
30.5
—
6
34
(3027008) Opiates [Presence] in Urine
48
426
1.13
0.32
2.5
1.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
38
433
0.87
0.32
2.9
1.7
mg/l
4.3
4.3
0.00
31
316
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
190
1998
0.94
0.30
4.3
4.2
%
20.0
21.3
0.54
103
909
(3013139) Helicobacter pylori Ag [Presence] in Stool
76
700
1.09
0.28
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
59
538
1.10
0.27
1.7
1.8
—
—
—
0
0
(4268621)
15
122
1.23
0.27
2.3
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
130
1229
1.06
0.26
16.8
6.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
47
426
1.11
0.24
2.6
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
47
428
1.10
0.23
2.6
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1008
9994
1.04
0.21
33.6
14.5
%
38.1
39.7
3.95
584
7389
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
118
1121
1.06
0.21
2.1
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
45
412
1.10
0.20
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
46
422
1.09
0.20
2.6
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
50
1.20
0.19
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
42
458
0.91
0.19
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
236
0.89
0.17
2.5
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
70
0.71
0.16
6.0
14.9
nmol/l
743.6
835.7
—
5
65
(3035320) C reactive protein [Mass/volume] in Body fluid
8
72
1.11
0.16
6.3
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
151
0.86
0.15
1.2
1.5
—
—
—
0
0
(4146454)
8
99
0.81
0.13
2.1
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
128
1241
1.03
0.12
2.1
2.1
—
—
—
0
0
(4024509)
10
87
1.15
0.09
1.2
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
55
1.09
0.09
1.2
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
57
1.05
0.08
1.2
1.5
mmol/l
8.5
6.1
—
6
57
(3025130) Human papilloma virus identified in Specimen
14
154
0.91
0.08
1.7
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
111
1137
0.97
0.08
1.9
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
170
0.94
0.04
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
201
1.05
0.03
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
202
1.04
0.02
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
148
1.01
0.00
1.0
1.2
—
—
—
0
0
(4094501)
28
275
1.02
0.00
1.1
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
69
1.01
0.00
1.4
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
8.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
85
0.94
0.00
1.3
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
13.1
—
0
8
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
64
0.94
0.00
3.3
1.9
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
382.6
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ADDISON and mortality.

Females

Parameter HR [95% CI] p-value
E4_ADDISON 3.11 [2.63, 3.68] < 0.001
Birth year 0.992 [0.98, 1.0] 0.064

During the follow-up period (1.1.1998 — 31.12.2019), 772 out of 3174 females with E4_ADDISON died.

Males

Parameter HR [95% CI] p-value
E4_ADDISON 3.382 [2.67, 4.29] < 0.001
Birth year 0.99 [0.98, 1.0] 0.035

During the follow-up period (1.1.1998 — 31.12.2019), 628 out of 2061 males with E4_ADDISON died.

Mortality risk

Mortality risk for people of age

years, who have E4_ADDISON.

N-year risk Females Males
1 0.367% 0.675%
5 1.877% 4.233%
10 4.403% 9.797%
15 7.805% 19.147%
20 13.146% 30.999%

Relationships between endpoints

↥

Index endpoint: E4_ADDISON – Adrenocortical insufficiency

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data